term_id,p_values,significant,term_size,query_sizes,intersection_sizes,source,term_name,effective_domain_size,source_order,parents,highlighted
KEGG:04612,7.63729497299219e-39,TRUE,69,88,29,KEGG,Antigen processing and presentation,8161,316,KEGG:00000,FALSE
GO:0048002,4.61918942397084e-29,TRUE,67,112,21,GO:BP,antigen processing and presentation of peptide antigen,21010,13106,GO:0019882,TRUE
KEGG:05332,5.1834929310886e-29,TRUE,37,88,20,KEGG,Graft-versus-host disease,8161,480,KEGG:00000,FALSE
GO:0019882,4.02271186937048e-27,TRUE,114,112,23,GO:BP,antigen processing and presentation,21010,6352,GO:0002376,FALSE
GO:0042611,5.87324579195311e-27,TRUE,24,112,15,GO:CC,MHC protein complex,22090,1812,GO:0098797,TRUE
GO:0005615,2.98747281016459e-26,TRUE,3284,112,68,GO:CC,extracellular space,22090,232,GO:0005576|GO:0110165,TRUE
GO:0042277,1.80777814770025e-24,TRUE,297,108,28,GO:MF,peptide binding,20139,5614,GO:0033218,TRUE
GO:0032994,1.90571857902246e-24,TRUE,41,112,16,GO:CC,protein-lipid complex,22090,1346,GO:0032991,FALSE
GO:0002483,2.08521182008885e-23,TRUE,24,112,14,GO:BP,antigen processing and presentation of endogenous peptide antigen,21010,1020,GO:0019883|GO:0048002,FALSE
GO:0033218,6.33115631565327e-23,TRUE,376,108,29,GO:MF,amide binding,20139,4539,GO:0005488,FALSE
GO:0034358,6.55922666030889e-23,TRUE,38,112,15,GO:CC,plasma lipoprotein particle,22090,1470,GO:0005615|GO:1990777,FALSE
GO:1990777,6.55922666030889e-23,TRUE,38,112,15,GO:CC,lipoprotein particle,22090,4011,GO:0032994,FALSE
GO:0005576,1.68008825188632e-21,TRUE,4206,112,70,GO:CC,extracellular region,22090,198,GO:0110165,FALSE
GO:0019883,2.73453731344164e-21,TRUE,31,112,14,GO:BP,antigen processing and presentation of endogenous antigen,21010,6353,GO:0019882,FALSE
GO:0031982,2.96554799521245e-21,TRUE,3976,112,68,GO:CC,vesicle,22090,1231,GO:0043227,FALSE
GO:0034364,8.23654685204238e-21,TRUE,28,112,13,GO:CC,high-density lipoprotein particle,22090,1476,GO:0034358,FALSE
GO:0009986,1.45227114749793e-20,TRUE,955,112,37,GO:CC,cell surface,22090,663,GO:0110165,FALSE
GO:0034385,1.46351495765199e-20,TRUE,21,112,12,GO:CC,triglyceride-rich plasma lipoprotein particle,22090,1479,GO:0034358,FALSE
GO:0034361,1.46351495765199e-20,TRUE,21,112,12,GO:CC,very-low-density lipoprotein particle,22090,1473,GO:0034385,FALSE
GO:0002474,2.35088546409313e-20,TRUE,35,112,14,GO:BP,antigen processing and presentation of peptide antigen via MHC class I,21010,1011,GO:0048002,FALSE
GO:0030139,1.3592225581506e-19,TRUE,342,112,25,GO:CC,endocytic vesicle,22090,917,GO:0031410,TRUE
GO:0098553,2.54625570657016e-19,TRUE,25,112,12,GO:CC,lumenal side of endoplasmic reticulum membrane,22090,3196,GO:0005789|GO:0098576,FALSE
GO:0023023,2.66810101755674e-19,TRUE,32,108,13,GO:MF,MHC protein complex binding,20139,3841,GO:0044877,TRUE
GO:0019885,3.06062536967797e-19,TRUE,22,112,12,GO:BP,antigen processing and presentation of endogenous peptide antigen via MHC class I,21010,6355,GO:0002474|GO:0002483,FALSE
GO:0031410,3.34017078604872e-19,TRUE,2476,112,53,GO:CC,cytoplasmic vesicle,22090,1109,GO:0005737|GO:0097708,FALSE
GO:0097708,3.6669985115743e-19,TRUE,2481,112,53,GO:CC,intracellular vesicle,22090,3144,GO:0031982|GO:0043231,FALSE
GO:0002396,1.23942995959104e-18,TRUE,17,112,11,GO:BP,MHC protein complex assembly,21010,934,GO:0065003,FALSE
GO:0002501,1.23942995959104e-18,TRUE,17,112,11,GO:BP,peptide antigen assembly with MHC protein complex,21010,1038,GO:0002396|GO:0048002|GO:0065003,FALSE
GO:0005102,1.54316567871318e-18,TRUE,1484,108,43,GO:MF,signaling receptor binding,20139,1280,GO:0005515,TRUE
GO:0042605,1.7439386094277e-18,TRUE,36,108,13,GO:MF,peptide antigen binding,20139,5657,GO:0003823|GO:0042277,FALSE
GO:0030666,2.92218694167437e-18,TRUE,194,112,20,GO:CC,endocytic vesicle membrane,22090,957,GO:0030139|GO:0030659|GO:0098588,FALSE
GO:0001914,3.28515951346238e-18,TRUE,47,112,14,GO:BP,regulation of T cell mediated cytotoxicity,21010,542,GO:0001910|GO:0001913|GO:0002709,TRUE
GO:0001912,8.65169219857354e-18,TRUE,65,112,15,GO:BP,positive regulation of leukocyte mediated cytotoxicity,21010,540,GO:0001909|GO:0001910|GO:0002705|GO:0031343,TRUE
KEGG:05330,9.58992125234308e-18,TRUE,34,88,14,KEGG,Allograft rejection,8161,479,KEGG:00000,FALSE
GO:0002376,3.57460920110435e-17,TRUE,2730,112,55,GO:BP,immune system process,21010,920,GO:0008150,FALSE
GO:0098576,3.91808306260638e-17,TRUE,35,112,12,GO:CC,lumenal side of membrane,22090,3217,GO:0031090|GO:0098552,FALSE
GO:0001913,4.04244257478276e-17,TRUE,55,112,14,GO:BP,T cell mediated cytotoxicity,21010,541,GO:0001909|GO:0002456,FALSE
GO:0001910,4.51263463376593e-17,TRUE,91,112,16,GO:BP,regulation of leukocyte mediated cytotoxicity,21010,538,GO:0001909|GO:0002703|GO:0031341,FALSE
GO:0031343,4.67608472945956e-17,TRUE,72,112,15,GO:BP,positive regulation of cell killing,21010,7480,GO:0001906|GO:0031341|GO:0048522,FALSE
KEGG:04940,1.51907092179005e-16,TRUE,40,88,14,KEGG,Type I diabetes mellitus,8161,387,KEGG:00000,FALSE
GO:0002428,1.6510782939889e-16,TRUE,16,112,10,GO:BP,antigen processing and presentation of peptide antigen via MHC class Ib,21010,965,GO:0002475|GO:0048002,FALSE
GO:0005768,3.11480894216237e-16,TRUE,1047,112,34,GO:CC,endosome,22090,336,GO:0012505|GO:0031410,FALSE
GO:0042627,3.68779503691787e-16,TRUE,13,112,9,GO:CC,chylomicron,22090,1816,GO:0034358,FALSE
GO:0031341,5.98762130141157e-16,TRUE,106,112,16,GO:BP,regulation of cell killing,21010,7478,GO:0001906|GO:0050794,FALSE
GO:0001909,8.20459938732364e-16,TRUE,133,112,17,GO:BP,leukocyte mediated cytotoxicity,21010,537,GO:0001906|GO:0002443,FALSE
GO:0002478,8.20707599301839e-16,TRUE,37,112,12,GO:BP,antigen processing and presentation of exogenous peptide antigen,21010,1015,GO:0019884|GO:0048002,FALSE
GO:0003823,8.31016516911125e-16,TRUE,115,108,16,GO:MF,antigen binding,20139,367,GO:0005488,FALSE
GO:0001916,1.19422037492776e-15,TRUE,38,112,12,GO:BP,positive regulation of T cell mediated cytotoxicity,21010,544,GO:0001912|GO:0001913|GO:0001914|GO:0002711,FALSE
GO:0002682,2.42281677096173e-15,TRUE,1482,112,40,GO:BP,regulation of immune system process,21010,1214,GO:0002376|GO:0050789,FALSE
GO:0012505,2.46949911684115e-15,TRUE,4742,112,66,GO:CC,endomembrane system,22090,689,GO:0110165,FALSE
GO:0002252,3.65692295961025e-15,TRUE,628,112,28,GO:BP,immune effector process,21010,798,GO:0002376,FALSE
GO:0033344,3.68608042152562e-15,TRUE,56,112,13,GO:BP,cholesterol efflux,21010,8533,GO:0030301,TRUE
REAC:R-HSA-983170,3.74094861439732e-15,TRUE,29,100,12,REAC,"Antigen Presentation: Folding, assembly and peptide loading of class I MHC",10835,146,REAC:R-HSA-983169,FALSE
KEGG:05320,4.09327223815417e-15,TRUE,49,88,14,KEGG,Autoimmune thyroid disease,8161,475,KEGG:00000,FALSE
GO:0034369,5.16535788306781e-15,TRUE,30,112,11,GO:BP,plasma lipoprotein particle remodeling,21010,8986,GO:0034368|GO:0071827|GO:0097006,FALSE
GO:0034368,5.16535788306781e-15,TRUE,30,112,11,GO:BP,protein-lipid complex remodeling,21010,8985,GO:0034367|GO:0071825,TRUE
GO:0002708,7.14056710304096e-15,TRUE,123,112,16,GO:BP,positive regulation of lymphocyte mediated immunity,21010,1240,GO:0002449|GO:0002705|GO:0002706,FALSE
GO:0002697,8.33262610177616e-15,TRUE,381,112,23,GO:BP,regulation of immune effector process,21010,1229,GO:0002252|GO:0002682,FALSE
GO:0033700,8.45348623447669e-15,TRUE,14,112,9,GO:BP,phospholipid efflux,21010,8740,GO:0015914,FALSE
GO:0051240,9.45795368639688e-15,TRUE,1629,112,41,GO:BP,positive regulation of multicellular organismal process,21010,14271,GO:0032501|GO:0048518|GO:0051239,TRUE
GO:0051239,1.05280750362671e-14,TRUE,2968,112,54,GO:BP,regulation of multicellular organismal process,21010,14270,GO:0032501|GO:0050789,FALSE
GO:0034367,1.20927149829023e-14,TRUE,32,112,11,GO:BP,protein-containing complex remodeling,21010,8984,GO:0043933,FALSE
GO:0042613,1.23292715253617e-14,TRUE,17,112,9,GO:CC,MHC class II protein complex,22090,1814,GO:0042611,FALSE
GO:0071827,1.65681150576377e-14,TRUE,46,112,12,GO:BP,plasma lipoprotein particle organization,21010,17749,GO:0032501|GO:0071825,FALSE
GO:0019884,1.65681150576377e-14,TRUE,46,112,12,GO:BP,antigen processing and presentation of exogenous antigen,21010,6354,GO:0019882,FALSE
GO:0071944,2.08719343456796e-14,TRUE,6202,112,74,GO:CC,cell periphery,22090,2799,GO:0110165,FALSE
GO:0002484,2.10404305103982e-14,TRUE,15,112,9,GO:BP,antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway,21010,1021,GO:0019885,FALSE
GO:0002476,2.10404305103982e-14,TRUE,15,112,9,GO:BP,antigen processing and presentation of endogenous peptide antigen via MHC class Ib,21010,1013,GO:0002428|GO:0002483,FALSE
GO:0006955,2.26431182432017e-14,TRUE,1951,112,44,GO:BP,immune response,21010,2628,GO:0002376|GO:0050896,FALSE
GO:0002475,2.28686493457226e-14,TRUE,23,112,10,GO:BP,antigen processing and presentation via MHC class Ib,21010,1012,GO:0019882,FALSE
KEGG:05416,3.31460294272103e-14,TRUE,56,88,14,KEGG,Viral myocarditis,8161,486,KEGG:00000,FALSE
GO:0071825,3.87696897003543e-14,TRUE,49,112,12,GO:BP,protein-lipid complex organization,21010,17747,GO:0043933,FALSE
GO:0046977,6.08741042308716e-14,TRUE,7,108,7,GO:MF,TAP binding,20139,6311,GO:0005515,FALSE
GO:0002705,1.06058383986865e-13,TRUE,145,112,16,GO:BP,positive regulation of leukocyte mediated immunity,21010,1237,GO:0002443|GO:0002699|GO:0002703,FALSE
GO:0097006,1.28911684131974e-13,TRUE,72,112,13,GO:BP,regulation of plasma lipoprotein particle levels,21010,19317,GO:0050789,FALSE
GO:0002709,1.5933871088628e-13,TRUE,95,112,14,GO:BP,regulation of T cell mediated immunity,21010,1241,GO:0002456|GO:0002706|GO:0002822,FALSE
GO:0006898,1.78974244660606e-13,TRUE,255,112,19,GO:BP,receptor-mediated endocytosis,21010,2592,GO:0006897,TRUE
GO:0002706,1.84980458849363e-13,TRUE,182,112,17,GO:BP,regulation of lymphocyte mediated immunity,21010,1238,GO:0002449|GO:0002703,FALSE
GO:0034366,1.86604561299386e-13,TRUE,8,112,7,GO:CC,spherical high-density lipoprotein particle,22090,1478,GO:0034364,FALSE
GO:0042612,1.86604561299386e-13,TRUE,8,112,7,GO:CC,MHC class I protein complex,22090,1813,GO:0042611,FALSE
GO:0001906,1.98263708234299e-13,TRUE,218,112,18,GO:BP,cell killing,21010,535,GO:0009987,FALSE
GO:0043691,2.01698098549057e-13,TRUE,18,112,9,GO:BP,reverse cholesterol transport,21010,11360,GO:0030301,FALSE
GO:0002699,2.96139886955499e-13,TRUE,262,112,19,GO:BP,positive regulation of immune effector process,21010,1231,GO:0002252|GO:0002684|GO:0002697,FALSE
GO:0034372,4.23981839490658e-13,TRUE,12,112,8,GO:BP,very-low-density lipoprotein particle remodeling,21010,8989,GO:0034370,FALSE
GO:0034370,4.23981839490658e-13,TRUE,12,112,8,GO:BP,triglyceride-rich lipoprotein particle remodeling,21010,8987,GO:0034369,FALSE
WP:WP430,6.86813423208959e-13,TRUE,31,87,11,WP,Statin inhibition of cholesterol production,8625,374,WP:000000,FALSE
REAC:R-HSA-8963901,7.43780812722158e-13,TRUE,10,100,8,REAC,Chylomicron remodeling,10835,349,REAC:R-HSA-8963899,FALSE
GO:0042824,8.36227009979876e-13,TRUE,9,112,7,GO:CC,MHC class I peptide loading complex,22090,1846,GO:0005789|GO:0098796|GO:0140534,TRUE
GO:0048583,8.46677440771941e-13,TRUE,3909,112,59,GO:BP,regulation of response to stimulus,21010,13506,GO:0050789|GO:0050896,FALSE
KEGG:04145,9.61718661204834e-13,TRUE,147,88,18,KEGG,Phagosome,8161,276,KEGG:00000,FALSE
GO:0002399,1.09750080223959e-12,TRUE,13,112,8,GO:BP,MHC class II protein complex assembly,21010,937,GO:0002396,FALSE
GO:0002503,1.09750080223959e-12,TRUE,13,112,8,GO:BP,peptide antigen assembly with MHC class II protein complex,21010,1040,GO:0002399|GO:0002495|GO:0002501,FALSE
GO:0002250,1.13779164025749e-12,TRUE,718,112,27,GO:BP,adaptive immune response,21010,796,GO:0006955,FALSE
GO:0030301,1.17559457175727e-12,TRUE,109,112,14,GO:BP,cholesterol transport,21010,7075,GO:0015918,FALSE
GO:0005769,1.23302795443199e-12,TRUE,428,112,21,GO:CC,early endosome,22090,337,GO:0005768,FALSE
GO:0001775,1.30529803801615e-12,TRUE,1082,112,32,GO:BP,cell activation,21010,450,GO:0009987|GO:0032501,FALSE
REAC:R-HSA-975634,1.35773170671733e-12,TRUE,44,100,12,REAC,Retinoid metabolism and transport,10835,1987,REAC:R-HSA-2187338|REAC:R-HSA-6806667,FALSE
GO:0006897,1.44440417270248e-12,TRUE,725,112,27,GO:BP,endocytosis,21010,2591,GO:0016192|GO:0098657,FALSE
GO:0002449,1.7020992640066e-12,TRUE,288,112,19,GO:BP,lymphocyte mediated immunity,21010,986,GO:0002443,FALSE
GO:0002711,1.91923141971111e-12,TRUE,66,112,12,GO:BP,positive regulation of T cell mediated immunity,21010,1243,GO:0002456|GO:0002708|GO:0002709|GO:0002824,FALSE
GO:0005886,2.41683594155058e-12,TRUE,5717,112,68,GO:CC,plasma membrane,22090,424,GO:0016020|GO:0071944,FALSE
GO:0002486,2.54956389024641e-12,TRUE,14,112,8,GO:BP,"antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway, TAP-independent",21010,1023,GO:0002484,FALSE
GO:0050896,2.56591117503085e-12,TRUE,8955,112,89,GO:BP,response to stimulus,21010,14004,GO:0008150,FALSE
GO:0012507,2.58538669514417e-12,TRUE,59,112,11,GO:CC,ER to Golgi transport vesicle membrane,22090,691,GO:0030134|GO:0030658|GO:0030662,FALSE
GO:0070062,2.63666505375995e-12,TRUE,2109,112,41,GO:CC,extracellular exosome,22090,2423,GO:0005615|GO:1903561,FALSE
GO:1903561,3.87709217181678e-12,TRUE,2133,112,41,GO:CC,extracellular vesicle,22090,3686,GO:0031982|GO:0065010,FALSE
GO:0043230,3.93941911604991e-12,TRUE,2134,112,41,GO:CC,extracellular organelle,22090,1886,GO:0005576|GO:0043226,FALSE
GO:0065010,3.93941911604991e-12,TRUE,2134,112,41,GO:CC,extracellular membrane-bounded organelle,22090,2403,GO:0043227|GO:0043230,FALSE
REAC:R-HSA-6806667,4.35166107967956e-12,TRUE,48,100,12,REAC,Metabolism of fat-soluble vitamins,10835,1356,REAC:R-HSA-196854,FALSE
GO:0005783,4.9162520701405e-12,TRUE,2041,112,40,GO:CC,endoplasmic reticulum,22090,348,GO:0005737|GO:0012505|GO:0043231,FALSE
GO:0098797,5.23828930241184e-12,TRUE,715,112,25,GO:CC,plasma membrane protein complex,22090,3266,GO:0005886|GO:0098796,FALSE
REAC:R-HSA-8963898,6.47485296745897e-12,TRUE,18,100,9,REAC,Plasma lipoprotein assembly,10835,1674,REAC:R-HSA-174824,FALSE
GO:0015918,6.6548713249549e-12,TRUE,123,112,14,GO:BP,sterol transport,21010,5099,GO:0006869|GO:0015850,FALSE
GO:0002456,7.46908659573829e-12,TRUE,124,112,14,GO:BP,T cell mediated immunity,21010,993,GO:0002449|GO:0002460,FALSE
GO:0030134,8.88738605447865e-12,TRUE,89,112,12,GO:CC,COPII-coated ER to Golgi transport vesicle,22090,913,GO:0030135,FALSE
GO:0005788,9.12936179258324e-12,TRUE,313,112,18,GO:CC,endoplasmic reticulum lumen,22090,353,GO:0005783|GO:0070013,FALSE
KEGG:04979,1.077889319469e-11,TRUE,51,88,12,KEGG,Cholesterol metabolism,8161,403,KEGG:00000,FALSE
GO:0060228,1.20154739262759e-11,TRUE,6,108,6,GO:MF,phosphatidylcholine-sterol O-acyltransferase activator activity,20139,8451,GO:0008047,TRUE
GO:0001540,1.43928772692484e-11,TRUE,84,108,12,GO:MF,amyloid-beta binding,20139,195,GO:0042277,FALSE
KEGG:05169,1.49407811538494e-11,TRUE,198,88,19,KEGG,Epstein-Barr virus infection,8161,443,KEGG:00000,FALSE
GO:0032501,1.75366914709793e-11,TRUE,7648,112,81,GO:BP,multicellular organismal process,21010,7975,GO:0008150,FALSE
GO:0002684,2.08739102678885e-11,TRUE,1033,112,30,GO:BP,positive regulation of immune system process,21010,1216,GO:0002376|GO:0002682|GO:0048518,FALSE
WP:WP2328,2.24738196848699e-11,TRUE,88,87,14,WP,Allograft rejection,8625,476,WP:000000,FALSE
GO:0002703,2.36104408785802e-11,TRUE,243,112,17,GO:BP,regulation of leukocyte mediated immunity,21010,1235,GO:0002443|GO:0002697,FALSE
REAC:R-HSA-174824,2.50518798194234e-11,TRUE,71,100,13,REAC,"Plasma lipoprotein assembly, remodeling, and clearance",10835,1675,REAC:R-HSA-382551,FALSE
GO:0030662,2.73560569396819e-11,TRUE,198,112,15,GO:CC,coated vesicle membrane,22090,954,GO:0030135|GO:0030659|GO:0098588,FALSE
GO:0002443,2.97021190214619e-11,TRUE,387,112,20,GO:BP,leukocyte mediated immunity,21010,980,GO:0002252,FALSE
GO:0032371,4.17206622115094e-11,TRUE,62,112,11,GO:BP,regulation of sterol transport,21010,7889,GO:0015918|GO:0032368,FALSE
GO:0032374,4.17206622115094e-11,TRUE,62,112,11,GO:BP,regulation of cholesterol transport,21010,7892,GO:0030301|GO:0032371,FALSE
GO:0072562,6.77702679320319e-11,TRUE,136,112,13,GO:CC,blood microparticle,22090,2820,GO:0005615|GO:0110165,FALSE
GO:0048518,6.91256727317998e-11,TRUE,6253,112,72,GO:BP,positive regulation of biological process,21010,13451,GO:0008150|GO:0050789,FALSE
GO:0030659,7.19519788555793e-11,TRUE,1213,112,30,GO:CC,cytoplasmic vesicle membrane,22090,951,GO:0012506|GO:0031410,FALSE
GO:0012506,1.0295399266385e-10,TRUE,1230,112,30,GO:CC,vesicle membrane,22090,690,GO:0031090|GO:0031982,FALSE
GO:0030135,1.08982558658344e-10,TRUE,310,112,17,GO:CC,coated vesicle,22090,914,GO:0031410,FALSE
GO:0002822,1.25999613755597e-10,TRUE,187,112,15,GO:BP,regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains,21010,1346,GO:0002460|GO:0002819,FALSE
GO:0002824,1.28946472031248e-10,TRUE,120,112,13,GO:BP,positive regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains,21010,1348,GO:0002460|GO:0002821|GO:0002822,FALSE
GO:0050776,1.37557970163961e-10,TRUE,875,112,27,GO:BP,regulation of immune response,21010,13908,GO:0002682|GO:0006955|GO:0048583,FALSE
GO:0098588,1.65542629032962e-10,TRUE,2160,112,39,GO:CC,bounding membrane of organelle,22090,3223,GO:0031090,FALSE
GO:0023026,2.09259408352573e-10,TRUE,24,108,8,GO:MF,MHC class II protein complex binding,20139,3844,GO:0023023,FALSE
GO:0098796,2.11296190491178e-10,TRUE,1357,112,31,GO:CC,membrane protein complex,22090,3265,GO:0016020|GO:0032991,FALSE
GO:0006952,2.26914183829652e-10,TRUE,1769,112,37,GO:BP,defense response,21010,2625,GO:0006950,FALSE
GO:0002821,2.44815858938564e-10,TRUE,126,112,13,GO:BP,positive regulation of adaptive immune response,21010,1345,GO:0002250|GO:0002819|GO:0050778,FALSE
WP:WP5323,2.8481948185175e-10,TRUE,381,87,23,WP,Fatty Acids and Lipoproteins Transport in Hepatocytes,8625,167,WP:000000,FALSE
GO:1905952,2.94355571224e-10,TRUE,161,112,14,GO:BP,regulation of lipid localization,21010,26082,GO:0010876|GO:0032879,FALSE
GO:0051249,3.03236237625538e-10,TRUE,496,112,21,GO:BP,regulation of lymphocyte activation,21010,14277,GO:0002694|GO:0046649,FALSE
GO:0002504,3.60657325017491e-10,TRUE,36,112,9,GO:BP,antigen processing and presentation of peptide or polysaccharide antigen via MHC class II,21010,1041,GO:0019882,FALSE
GO:0002819,3.92341248513613e-10,TRUE,202,112,15,GO:BP,regulation of adaptive immune response,21010,1343,GO:0002250|GO:0050776,FALSE
GO:0043235,4.60300703752811e-10,TRUE,515,112,20,GO:CC,receptor complex,22090,1890,GO:0032991,TRUE
GO:0050865,5.00009424821561e-10,TRUE,636,112,23,GO:BP,regulation of cell activation,21010,13978,GO:0001775|GO:0050794|GO:0051239,FALSE
GO:0009605,5.36580672414645e-10,TRUE,2686,112,45,GO:BP,response to external stimulus,21010,3590,GO:0050896,FALSE
GO:0032368,5.47348015111298e-10,TRUE,134,112,13,GO:BP,regulation of lipid transport,21010,7886,GO:0006869|GO:0051049|GO:1905952,FALSE
REAC:R-HSA-1236977,6.25595003861114e-10,TRUE,11,100,7,REAC,Endosomal/Vacuolar pathway,10835,808,REAC:R-HSA-1236975,FALSE
GO:0048522,6.95427982804044e-10,TRUE,5711,112,67,GO:BP,positive regulation of cellular process,21010,13455,GO:0009987|GO:0048518|GO:0050794,FALSE
GO:0098657,7.33800667611778e-10,TRUE,939,112,27,GO:BP,import into cell,21010,19705,GO:0006810,FALSE
GO:0045321,7.33800667611778e-10,TRUE,939,112,27,GO:BP,leukocyte activation,21010,11966,GO:0001775|GO:0002376,FALSE
GO:0009607,1.05869898273888e-09,TRUE,1565,112,34,GO:BP,response to biotic stimulus,21010,3592,GO:0050896,FALSE
GO:0070325,1.19450052583575e-09,TRUE,29,108,8,GO:MF,lipoprotein particle receptor binding,20139,8710,GO:0005102,FALSE
GO:0034377,1.25800158943398e-09,TRUE,26,112,8,GO:BP,plasma lipoprotein particle assembly,21010,8994,GO:0065005|GO:0071827|GO:0097006,FALSE
GO:0010008,1.57540170880597e-09,TRUE,551,112,20,GO:CC,endosome membrane,22090,667,GO:0005768|GO:0030659|GO:0098588,FALSE
GO:0010876,1.70281064773657e-09,TRUE,481,112,20,GO:BP,lipid localization,21010,4545,GO:0033036,FALSE
GO:0034375,1.91774061753113e-09,TRUE,16,112,7,GO:BP,high-density lipoprotein particle remodeling,21010,8992,GO:0034369,FALSE
WP:WP5110,2.26439642919007e-09,TRUE,13,87,7,WP,Familial hyperlipidemia type 3,8625,410,WP:000000,FALSE
GO:0030670,2.31243262725475e-09,TRUE,78,112,10,GO:CC,phagocytic vesicle membrane,22090,961,GO:0030666|GO:0045335,FALSE
GO:0045335,2.397728098976e-09,TRUE,141,112,12,GO:CC,phagocytic vesicle,22090,2193,GO:0030139,FALSE
GO:0019886,2.48078197245149e-09,TRUE,28,112,8,GO:BP,antigen processing and presentation of exogenous peptide antigen via MHC class II,21010,6356,GO:0002478|GO:0002495,FALSE
GO:0051251,2.56111392670925e-09,TRUE,324,112,17,GO:BP,positive regulation of lymphocyte activation,21010,14279,GO:0002696|GO:0046649|GO:0051249,FALSE
GO:0006869,2.71784764174685e-09,TRUE,434,112,19,GO:BP,lipid transport,21010,2570,GO:0010876|GO:0071702,FALSE
GO:0051707,2.97138940997807e-09,TRUE,1527,112,33,GO:BP,response to other organism,21010,14600,GO:0043207|GO:0044419,FALSE
GO:0043207,3.13540554146113e-09,TRUE,1530,112,33,GO:BP,response to external biotic stimulus,21010,11085,GO:0009605|GO:0009607,FALSE
GO:0045953,3.24590144685097e-09,TRUE,17,112,7,GO:BP,negative regulation of natural killer cell mediated cytotoxicity,21010,12362,GO:0001911|GO:0002716|GO:0042267|GO:0042269,FALSE
GO:0042269,3.26233799832326e-09,TRUE,45,112,9,GO:BP,regulation of natural killer cell mediated cytotoxicity,21010,10567,GO:0001910|GO:0002715|GO:0042267,FALSE
GO:0065005,3.4107661417126e-09,TRUE,29,112,8,GO:BP,protein-lipid complex assembly,21010,16681,GO:0065003|GO:0071825,FALSE
KEGG:04650,3.46996682067226e-09,TRUE,124,88,14,KEGG,Natural killer cell mediated cytotoxicity,8161,328,KEGG:00000,FALSE
GO:0050867,3.88173613383083e-09,TRUE,386,112,18,GO:BP,positive regulation of cell activation,21010,13980,GO:0001775|GO:0048522|GO:0050865|GO:0051240,FALSE
WP:WP4217,4.4128036159319e-09,TRUE,128,87,14,WP,Ebola virus infection in host,8625,813,WP:000000,FALSE
GO:0006810,4.83691767065355e-09,TRUE,4716,112,59,GO:BP,transport,21010,2530,GO:0051234,FALSE
KEGG:04514,5.10384385386549e-09,TRUE,153,88,15,KEGG,Cell adhesion molecules,8161,309,KEGG:00000,FALSE
GO:0002716,5.28824715450311e-09,TRUE,18,112,7,GO:BP,negative regulation of natural killer cell mediated immunity,21010,1248,GO:0002228|GO:0002707|GO:0002715|GO:0045824,FALSE
GO:0050870,6.09911564430024e-09,TRUE,244,112,15,GO:BP,positive regulation of T cell activation,21010,13983,GO:0042110|GO:0050863|GO:0051251|GO:1903039,FALSE
GO:0002694,7.11707333323921e-09,TRUE,585,112,21,GO:BP,regulation of leukocyte activation,21010,1226,GO:0002682|GO:0045321|GO:0050865,FALSE
GO:0051234,7.19052044334199e-09,TRUE,4905,112,60,GO:BP,establishment of localization,21010,14265,GO:0051179,FALSE
GO:0002715,7.43066472423872e-09,TRUE,49,112,9,GO:BP,regulation of natural killer cell mediated immunity,21010,1247,GO:0002228|GO:0002706|GO:0045088,FALSE
GO:0002495,8.24854208134283e-09,TRUE,32,112,8,GO:BP,antigen processing and presentation of peptide antigen via MHC class II,21010,1032,GO:0002504|GO:0048002,FALSE
WP:WP5112,8.35412660416276e-09,TRUE,15,87,7,WP,Familial hyperlipidemia type 5,8625,163,WP:000000,FALSE
GO:0042267,8.62841536897122e-09,TRUE,72,112,10,GO:BP,natural killer cell mediated cytotoxicity,21010,10565,GO:0001909|GO:0002228,FALSE
GO:0048584,8.72897288439001e-09,TRUE,2212,112,39,GO:BP,positive regulation of response to stimulus,21010,13507,GO:0048518|GO:0048583|GO:0050896,FALSE
GO:0055037,1.00779355774707e-08,TRUE,201,112,13,GO:CC,recycling endosome,22090,2259,GO:0005768,FALSE
GO:0044419,1.04049054698403e-08,TRUE,1698,112,34,GO:BP,biological process involved in interspecies interaction between organisms,21010,11569,GO:0008150,FALSE
GO:0002460,1.05988600226996e-08,TRUE,302,112,16,GO:BP,adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains,21010,997,GO:0002250,FALSE
GO:0022407,1.21980022964739e-08,TRUE,473,112,19,GO:BP,regulation of cell-cell adhesion,21010,6913,GO:0030155|GO:0098609,FALSE
GO:0002228,1.31627055778785e-08,TRUE,75,112,10,GO:BP,natural killer cell mediated immunity,21010,775,GO:0002449|GO:0045087,FALSE
GO:0023029,1.40323237195903e-08,TRUE,6,108,5,GO:MF,MHC class Ib protein binding,20139,3847,GO:0042287,FALSE
GO:0034384,1.56215049768824e-08,TRUE,11,112,6,GO:BP,high-density lipoprotein particle clearance,21010,9001,GO:0034381,FALSE
WP:WP5304,1.75613162466746e-08,TRUE,72,87,11,WP,Cholesterol metabolism,8625,508,WP:000000,FALSE
GO:0022409,1.90624926600983e-08,TRUE,314,112,16,GO:BP,positive regulation of cell-cell adhesion,21010,6915,GO:0022407|GO:0045785|GO:0098609,FALSE
GO:0042287,2.03859196379974e-08,TRUE,40,108,8,GO:MF,MHC protein binding,20139,5621,GO:0005102,FALSE
KEGG:05310,2.08063603133334e-08,TRUE,27,88,8,KEGG,Asthma,8161,474,KEGG:00000,FALSE
GO:0002696,2.20829035311527e-08,TRUE,371,112,17,GO:BP,positive regulation of leukocyte activation,21010,1228,GO:0002684|GO:0002694|GO:0045321|GO:0050867,FALSE
GO:1903039,2.21404904301782e-08,TRUE,267,112,15,GO:BP,positive regulation of leukocyte cell-cell adhesion,21010,23643,GO:0007159|GO:0022409|GO:1903037,FALSE
WP:WP5172,2.48396331430322e-08,TRUE,17,87,7,WP,Iron metabolism disorders,8625,838,WP:000000,FALSE
GO:0006950,2.65923247995367e-08,TRUE,3909,112,52,GO:BP,response to stress,21010,2624,GO:0050896,FALSE
GO:0046649,2.91079812066169e-08,TRUE,776,112,23,GO:BP,lymphocyte activation,21010,12911,GO:0045321,FALSE
WP:WP3601,2.99797518616227e-08,TRUE,10,87,6,WP,Lipid particles composition,8625,418,WP:000000,FALSE
REAC:R-HSA-2187338,3.07554868359543e-08,TRUE,97,100,12,REAC,Visual phototransduction,10835,2534,REAC:R-HSA-9709957,FALSE
GO:0016192,3.11002428996818e-08,TRUE,1566,112,32,GO:BP,vesicle-mediated transport,21010,5255,GO:0006810|GO:0009987,FALSE
GO:0098552,3.56438040886353e-08,TRUE,656,112,20,GO:CC,side of membrane,22090,3195,GO:0016020|GO:0110165,FALSE
REAC:R-HSA-198933,3.83161903552274e-08,TRUE,181,100,15,REAC,Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell,10835,1119,REAC:R-HSA-1280218,FALSE
GO:0001911,3.98552059926755e-08,TRUE,23,112,7,GO:BP,negative regulation of leukocyte mediated cytotoxicity,21010,539,GO:0001909|GO:0001910|GO:0002704|GO:0031342,FALSE
WP:WP5108,4.03166108937693e-08,TRUE,18,87,7,WP,Familial  hyperlipidemia type 1,8625,833,WP:000000,FALSE
GO:0010901,4.05262243856276e-08,TRUE,6,112,5,GO:BP,regulation of very-low-density lipoprotein particle remodeling,21010,4570,GO:0034372|GO:0051128|GO:0051239,FALSE
GO:0034447,4.05262243856276e-08,TRUE,6,112,5,GO:BP,very-low-density lipoprotein particle clearance,21010,9040,GO:0034381,FALSE
REAC:R-HSA-8963888,4.58765702339361e-08,TRUE,10,100,6,REAC,Chylomicron assembly,10835,347,REAC:R-HSA-8963898,FALSE
GO:0015850,5.31643151909981e-08,TRUE,284,112,15,GO:BP,organic hydroxy compound transport,21010,5044,GO:0071702,FALSE
GO:1990712,5.57244610649169e-08,TRUE,8,112,5,GO:CC,HFE-transferrin receptor complex,22090,3989,GO:0098802,FALSE
GO:0034381,5.82187859575065e-08,TRUE,40,112,8,GO:BP,plasma lipoprotein particle clearance,21010,8998,GO:0032501|GO:0097006,FALSE
GO:0033036,6.33485890044861e-08,TRUE,3204,112,46,GO:BP,macromolecule localization,21010,8369,GO:0051179,FALSE
GO:0071814,6.57182233054981e-08,TRUE,28,108,7,GO:MF,protein-lipid complex binding,20139,8865,GO:0044877,FALSE
GO:0071813,6.57182233054981e-08,TRUE,28,108,7,GO:MF,lipoprotein particle binding,20139,8864,GO:0071814,FALSE
GO:0042632,6.76645824075201e-08,TRUE,88,112,10,GO:BP,cholesterol homeostasis,21010,10768,GO:0055092,TRUE
GO:0055092,7.58929743005135e-08,TRUE,89,112,10,GO:BP,sterol homeostasis,21010,14972,GO:0055088,FALSE
GO:0007159,7.77786277683325e-08,TRUE,402,112,17,GO:BP,leukocyte cell-cell adhesion,21010,2770,GO:0098609,FALSE
GO:0002698,8.07291303134503e-08,TRUE,121,112,11,GO:BP,negative regulation of immune effector process,21010,1230,GO:0002252|GO:0002683|GO:0002697,FALSE
KEGG:05166,9.17390123014688e-08,TRUE,219,88,16,KEGG,Human T-cell leukemia virus 1 infection,8161,440,KEGG:00000,FALSE
GO:0031342,1.05542055385407e-07,TRUE,26,112,7,GO:BP,negative regulation of cell killing,21010,7479,GO:0001906|GO:0031341|GO:0048523,FALSE
GO:0045785,1.11617958231343e-07,TRUE,473,112,18,GO:BP,positive regulation of cell adhesion,21010,12232,GO:0007155|GO:0030155|GO:0048522,FALSE
GO:0051179,1.27518385979811e-07,TRUE,5542,112,62,GO:BP,localization,21010,14235,GO:0008150,FALSE
GO:0097647,1.41239712778077e-07,TRUE,7,112,5,GO:BP,amylin receptor signaling pathway,21010,19609,GO:0097646,TRUE
REAC:R-HSA-8963899,1.47146450558248e-07,TRUE,32,100,8,REAC,Plasma lipoprotein remodeling,10835,1677,REAC:R-HSA-174824,FALSE
REAC:R-HSA-877300,1.569344403613e-07,TRUE,87,100,11,REAC,Interferon gamma signaling,10835,1177,REAC:R-HSA-913531,FALSE
GO:0042110,1.57229389405156e-07,TRUE,549,112,19,GO:BP,T cell activation,21010,10466,GO:0046649,FALSE
GO:0006639,1.62360474246482e-07,TRUE,129,112,11,GO:BP,acylglycerol metabolic process,21010,2388,GO:0006638|GO:0046486,FALSE
GO:0071702,1.64019868442937e-07,TRUE,3039,112,44,GO:BP,organic substance transport,21010,17684,GO:0006810,FALSE
GO:0030133,1.65136914907301e-07,TRUE,427,112,16,GO:CC,transport vesicle,22090,912,GO:0012505|GO:0031410,FALSE
GO:1903037,1.7215524982281e-07,TRUE,364,112,16,GO:BP,regulation of leukocyte cell-cell adhesion,21010,23641,GO:0007159|GO:0022407,FALSE
GO:0006638,1.76585501552745e-07,TRUE,130,112,11,GO:BP,neutral lipid metabolic process,21010,2387,GO:0044255,FALSE
GO:0002683,1.79332332677754e-07,TRUE,487,112,18,GO:BP,negative regulation of immune system process,21010,1215,GO:0002376|GO:0002682|GO:0048519,FALSE
GO:0030155,1.81743088058111e-07,TRUE,772,112,22,GO:BP,regulation of cell adhesion,21010,7003,GO:0007155|GO:0050794,FALSE
GO:0050778,1.95909657561945e-07,TRUE,699,112,21,GO:BP,positive regulation of immune response,21010,13910,GO:0002684|GO:0006955|GO:0048584|GO:0050776,FALSE
WP:WP5111,2.09123493911752e-07,TRUE,22,87,7,WP,Familial hyperlipidemia type 4,8625,381,WP:000000,FALSE
REAC:R-HSA-1236974,2.27898309375319e-07,TRUE,90,100,11,REAC,ER-Phagosome pathway,10835,790,REAC:R-HSA-1236975,FALSE
GO:0050863,2.37146550491327e-07,TRUE,372,112,16,GO:BP,regulation of T cell activation,21010,13976,GO:0042110|GO:0051249,FALSE
GO:0051004,2.64968763737728e-07,TRUE,16,112,6,GO:BP,regulation of lipoprotein lipase activity,21010,14104,GO:0060191,TRUE
GO:0006641,2.71906916076578e-07,TRUE,101,112,10,GO:BP,triglyceride metabolic process,21010,2390,GO:0006639,FALSE
GO:0007155,2.85259135906027e-07,TRUE,1504,112,30,GO:BP,cell adhesion,21010,2766,GO:0009987,FALSE
GO:0015914,3.00130232585603e-07,TRUE,102,112,10,GO:BP,phospholipid transport,21010,5096,GO:0006869|GO:0015748,FALSE
GO:0000323,3.27406146548942e-07,TRUE,745,112,20,GO:CC,lytic vacuole,22090,53,GO:0005773,FALSE
GO:0005764,3.27406146548942e-07,TRUE,745,112,20,GO:CC,lysosome,22090,332,GO:0000323,FALSE
GO:1905918,3.75040651915985e-07,TRUE,8,112,5,GO:BP,regulation of CoA-transferase activity,21010,26056,GO:0051338,FALSE
GO:1905920,3.75040651915985e-07,TRUE,8,112,5,GO:BP,positive regulation of CoA-transferase activity,21010,26058,GO:0051347|GO:1905918,TRUE
GO:0042157,3.9410959183248e-07,TRUE,140,112,11,GO:BP,lipoprotein metabolic process,21010,10494,GO:0019538,TRUE
GO:0010039,4.12765317593933e-07,TRUE,31,112,7,GO:BP,response to iron ion,21010,3909,GO:0010038,TRUE
GO:0046978,4.54728358864547e-07,TRUE,4,108,4,GO:MF,TAP1 binding,20139,6312,GO:0046977,FALSE
GO:0044281,4.70772443123601e-07,TRUE,1846,112,33,GO:BP,small molecule metabolic process,21010,11506,GO:0008152,FALSE
REAC:R-HSA-196854,6.0979279784281e-07,TRUE,186,100,14,REAC,Metabolism of vitamins and cofactors,10835,1372,REAC:R-HSA-1430728,FALSE
GO:0051049,6.43636636542669e-07,TRUE,1762,112,32,GO:BP,regulation of transport,21010,14131,GO:0006810|GO:0032879,FALSE
GO:0016020,7.89323157542535e-07,TRUE,9853,112,81,GO:CC,membrane,22090,722,GO:0110165,FALSE
GO:0097646,8.40260214175441e-07,TRUE,9,112,5,GO:BP,calcitonin family receptor signaling pathway,21010,19608,GO:0007186,FALSE
GO:0002707,8.62740561068057e-07,TRUE,55,112,8,GO:BP,negative regulation of lymphocyte mediated immunity,21010,1239,GO:0002449|GO:0002704|GO:0002706,FALSE
GO:0048878,8.80028176187972e-07,TRUE,1008,112,24,GO:BP,chemical homeostasis,21010,13771,GO:0042592,FALSE
GO:0055038,8.8647487077129e-07,TRUE,103,112,9,GO:CC,recycling endosome membrane,22090,2260,GO:0010008|GO:0055037,FALSE
GO:0030669,9.09792355864359e-07,TRUE,71,112,8,GO:CC,clathrin-coated endocytic vesicle membrane,22090,960,GO:0030665|GO:0030666|GO:0045334,FALSE
GO:0032879,1.01630903736743e-06,TRUE,2123,112,35,GO:BP,regulation of localization,21010,8247,GO:0050789|GO:0051179,FALSE
REAC:R-HSA-1280218,1.03849911947445e-06,TRUE,809,100,27,REAC,Adaptive Immune System,10835,114,REAC:R-HSA-168256,FALSE
REAC:R-HSA-1236975,1.2179819205302e-06,TRUE,105,100,11,REAC,Antigen processing-Cross presentation,10835,148,REAC:R-HSA-983169,FALSE
GO:0098609,1.24732856317955e-06,TRUE,939,112,23,GO:BP,cell-cell adhesion,21010,19697,GO:0007155,FALSE
GO:0002477,1.31932567238782e-06,TRUE,4,112,4,GO:BP,antigen processing and presentation of exogenous peptide antigen via MHC class Ib,21010,1014,GO:0002428|GO:0002478,FALSE
GO:0031090,1.40217035033946e-06,TRUE,3734,112,45,GO:CC,organelle membrane,22090,1048,GO:0016020|GO:0043227,FALSE
GO:0006629,1.40694387685049e-06,TRUE,1406,112,28,GO:BP,lipid metabolic process,21010,2380,GO:0044238|GO:0071704,FALSE
GO:0005905,1.41872090192719e-06,TRUE,75,112,8,GO:CC,clathrin-coated pit,22090,440,GO:0012505|GO:0098590,FALSE
KEGG:04672,1.43119463139918e-06,TRUE,44,88,8,KEGG,Intestinal immune network for IgA production,8161,338,KEGG:00000,FALSE
WP:WP4522,1.66960289830781e-06,TRUE,17,87,6,WP,"Metabolic pathway of LDL, HDL and TG, including diseases",8625,790,WP:000000,FALSE
GO:0070328,1.9211818111681e-06,TRUE,38,112,7,GO:BP,triglyceride homeostasis,21010,16855,GO:0055090,FALSE
GO:0055090,1.9211818111681e-06,TRUE,38,112,7,GO:BP,acylglycerol homeostasis,21010,14970,GO:0055088,FALSE
GO:0005773,2.42405238792122e-06,TRUE,838,112,20,GO:CC,vacuole,22090,340,GO:0005737|GO:0043231,FALSE
GO:0046503,2.64915295867372e-06,TRUE,63,112,8,GO:BP,glycerolipid catabolic process,21010,12831,GO:0044242|GO:0046486,FALSE
GO:0008202,2.71997234609975e-06,TRUE,318,112,14,GO:BP,steroid metabolic process,21010,3182,GO:0006629|GO:1901360,FALSE
GO:0062012,3.46038894558837e-06,TRUE,324,112,14,GO:BP,regulation of small molecule metabolic process,21010,16573,GO:0019222|GO:0044281,FALSE
GO:0002704,3.87712954968839e-06,TRUE,66,112,8,GO:BP,negative regulation of leukocyte mediated immunity,21010,1236,GO:0002443|GO:0002698|GO:0002703,FALSE
GO:0046486,4.16995147986872e-06,TRUE,389,112,15,GO:BP,glycerolipid metabolic process,21010,12815,GO:0044255,FALSE
GO:0044877,4.19745170750922e-06,TRUE,1761,108,30,GO:MF,protein-containing complex binding,20139,6092,GO:0005488,FALSE
GO:0006879,4.94609178248315e-06,TRUE,68,112,8,GO:BP,intracellular iron ion homeostasis,21010,2575,GO:0030003|GO:0098771,TRUE
KEGG:04640,5.05531092288655e-06,TRUE,95,88,10,KEGG,Hematopoietic cell lineage,8161,327,KEGG:00000,FALSE
GO:0045334,5.11855810696272e-06,TRUE,88,112,8,GO:CC,clathrin-coated endocytic vesicle,22090,2192,GO:0030136|GO:0030139,FALSE
GO:0034380,5.2146859009343e-06,TRUE,12,112,5,GO:BP,high-density lipoprotein particle assembly,21010,8997,GO:0034377,FALSE
REAC:R-HSA-419812,6.23335202537784e-06,TRUE,10,100,5,REAC,Calcitonin-like ligand receptors,10835,292,REAC:R-HSA-373080,FALSE
GO:1905953,6.69956449100311e-06,TRUE,45,112,7,GO:BP,negative regulation of lipid localization,21010,26083,GO:0010876|GO:0048519|GO:1905952,FALSE
GO:0023024,6.76467593335058e-06,TRUE,6,108,4,GO:MF,MHC class I protein complex binding,20139,3842,GO:0023023,FALSE
GO:0005794,8.06021971023388e-06,TRUE,1613,112,27,GO:CC,Golgi apparatus,22090,358,GO:0005737|GO:0012505|GO:0043231,FALSE
GO:0032372,8.43791335479304e-06,TRUE,13,112,5,GO:BP,negative regulation of sterol transport,21010,7890,GO:0015918|GO:0032369|GO:0032371,FALSE
GO:0032375,8.43791335479304e-06,TRUE,13,112,5,GO:BP,negative regulation of cholesterol transport,21010,7893,GO:0030301|GO:0032372|GO:0032374,FALSE
GO:0006006,9.06221870405173e-06,TRUE,188,112,11,GO:BP,glucose metabolic process,21010,1903,GO:0019318,TRUE
GO:0030658,9.20573644344707e-06,TRUE,232,112,11,GO:CC,transport vesicle membrane,22090,950,GO:0030133|GO:0030659|GO:0098588,FALSE
GO:0005765,1.06432503583175e-05,TRUE,424,112,14,GO:CC,lysosomal membrane,22090,333,GO:0005764|GO:0098852,FALSE
GO:0098852,1.06432503583175e-05,TRUE,424,112,14,GO:CC,lytic vacuole membrane,22090,3292,GO:0000323|GO:0005774,FALSE
GO:0042175,1.07309456963177e-05,TRUE,1208,112,23,GO:CC,nuclear outer membrane-endoplasmic reticulum membrane network,22090,1781,GO:0012505|GO:0016020,FALSE
GO:0031328,1.07334765143393e-05,TRUE,2684,112,38,GO:BP,positive regulation of cellular biosynthetic process,21010,7466,GO:0009891|GO:0031325|GO:0031326|GO:0044249,FALSE
GO:0009897,1.16186017167877e-05,TRUE,427,112,14,GO:CC,external side of plasma membrane,22090,656,GO:0005886|GO:0009986|GO:0098552,FALSE
GO:0042886,1.19505320850802e-05,TRUE,357,112,14,GO:BP,amide transport,21010,10936,GO:0071705,FALSE
GO:0009891,1.30576814655001e-05,TRUE,2703,112,38,GO:BP,positive regulation of biosynthetic process,21010,3809,GO:0009058|GO:0009889|GO:0009893,FALSE
GO:0050789,1.32544332091055e-05,TRUE,12331,112,94,GO:BP,regulation of biological process,21010,13916,GO:0008150|GO:0065007,FALSE
GO:0015748,1.33237960786457e-05,TRUE,150,112,10,GO:BP,organophosphate ester transport,21010,4952,GO:0071702,FALSE
GO:0038024,1.37798567371969e-05,TRUE,88,108,8,GO:MF,cargo receptor activity,20139,5537,GO:0003674,TRUE
GO:0034185,1.38079463721364e-05,TRUE,17,108,5,GO:MF,apolipoprotein binding,20139,4957,GO:0005515,FALSE
GO:0032369,1.48568521632321e-05,TRUE,29,112,6,GO:BP,negative regulation of lipid transport,21010,7887,GO:0006869|GO:0032368|GO:0051051|GO:1905953,FALSE
GO:0030881,1.57190388107028e-05,TRUE,7,108,4,GO:MF,beta-2-microglobulin binding,20139,4088,GO:0005515,FALSE
GO:0099503,1.71988339348031e-05,TRUE,1039,112,21,GO:CC,secretory vesicle,22090,3371,GO:0031410,FALSE
GO:0042288,1.90372687231111e-05,TRUE,18,108,5,GO:MF,MHC class I protein binding,20139,5622,GO:0042287,FALSE
GO:0042270,1.96274346521173e-05,TRUE,6,112,4,GO:BP,protection from natural killer cell mediated cytotoxicity,21010,10568,GO:0045953,FALSE
GO:0034382,1.96274346521173e-05,TRUE,6,112,4,GO:BP,chylomicron remnant clearance,21010,8999,GO:0071830,FALSE
GO:0051050,2.3047739634521e-05,TRUE,913,112,21,GO:BP,positive regulation of transport,21010,14132,GO:0006810|GO:0048518|GO:0051049,FALSE
KEGG:05321,2.33207977704726e-05,TRUE,62,88,8,KEGG,Inflammatory bowel disease,8161,476,KEGG:00000,FALSE
GO:0002718,2.38326013300742e-05,TRUE,118,112,9,GO:BP,regulation of cytokine production involved in immune response,21010,1250,GO:0001817|GO:0002367|GO:0002700,FALSE
GO:0002367,2.38326013300742e-05,TRUE,118,112,9,GO:BP,cytokine production involved in immune response,21010,913,GO:0001816|GO:0002440|GO:0006955,FALSE
GO:0045824,2.47036672844314e-05,TRUE,83,112,8,GO:BP,negative regulation of innate immune response,21010,12259,GO:0002832|GO:0031348|GO:0032102|GO:0045087|GO:0045088|GO:0050777,FALSE
GO:0006090,2.56687793998918e-05,TRUE,119,112,9,GO:BP,pyruvate metabolic process,21010,1982,GO:0032787,FALSE
REAC:R-HSA-977225,2.6304113697064e-05,TRUE,110,100,10,REAC,Amyloid fiber formation,10835,140,REAC:R-HSA-392499,FALSE
GO:0055088,2.63088136444295e-05,TRUE,161,112,10,GO:BP,lipid homeostasis,21010,14968,GO:0048878,FALSE
GO:0060191,2.71839976590469e-05,TRUE,84,112,8,GO:BP,regulation of lipase activity,21010,15155,GO:0051336,FALSE
GO:0002717,2.79765266588803e-05,TRUE,32,112,6,GO:BP,positive regulation of natural killer cell mediated immunity,21010,1249,GO:0002228|GO:0002708|GO:0002715|GO:0045089,FALSE
GO:0032395,3.13082234167189e-05,TRUE,8,108,4,GO:MF,MHC class II receptor activity,20139,4448,GO:0004888|GO:0140375,TRUE
GO:0005789,3.49647040077017e-05,TRUE,1185,112,22,GO:CC,endoplasmic reticulum membrane,22090,354,GO:0031090|GO:0042175|GO:0098827,FALSE
HP:0000991,3.52072323083362e-05,TRUE,31,54,7,HP,Xanthomatosis,4962,774,HP:0011355,FALSE
GO:0005774,3.59965846693699e-05,TRUE,468,112,14,GO:CC,vacuolar membrane,22090,341,GO:0005773|GO:0098588,FALSE
GO:0015833,3.71611786553125e-05,TRUE,269,112,12,GO:BP,peptide transport,21010,5028,GO:0042886|GO:0071702,FALSE
GO:0098827,3.81691326945744e-05,TRUE,1191,112,22,GO:CC,endoplasmic reticulum subcompartment,22090,3276,GO:0005783|GO:0031984,FALSE
GO:0140375,3.95137090809426e-05,TRUE,141,108,9,GO:MF,immune receptor activity,20139,10570,GO:0038023,FALSE
GO:0006826,4.19335935139138e-05,TRUE,58,112,7,GO:BP,iron ion transport,21010,2541,GO:0000041,TRUE
GO:0071830,4.56090279045695e-05,TRUE,7,112,4,GO:BP,triglyceride-rich lipoprotein particle clearance,21010,17752,GO:0034381,FALSE
GO:0051006,4.56090279045695e-05,TRUE,7,112,4,GO:BP,positive regulation of lipoprotein lipase activity,21010,14106,GO:0051004|GO:0061365,FALSE
WP:WP534,4.6134503777761e-05,TRUE,45,87,7,WP,Glycolysis and gluconeogenesis,8625,326,WP:000000,FALSE
GO:0006096,4.70740674775364e-05,TRUE,90,112,8,GO:BP,glycolytic process,21010,1985,GO:0006090|GO:0006091|GO:0016052,FALSE
GO:0031348,4.74154937701668e-05,TRUE,275,112,12,GO:BP,negative regulation of defense response,21010,7485,GO:0006952|GO:0031347|GO:0048585,FALSE
WP:WP3942,5.17746477569844e-05,TRUE,67,87,8,WP,PPAR signaling pathway,8625,707,WP:000000,FALSE
GO:0051604,5.29653173091409e-05,TRUE,543,112,16,GO:BP,protein maturation,21010,14517,GO:0010467|GO:0019538,TRUE
GO:0046461,5.91011212316851e-05,TRUE,36,112,6,GO:BP,neutral lipid catabolic process,21010,12793,GO:0006638|GO:0044242,FALSE
GO:0046464,5.91011212316851e-05,TRUE,36,112,6,GO:BP,acylglycerol catabolic process,21010,12796,GO:0006639|GO:0046461|GO:0046503,FALSE
GO:0009893,6.03112175290693e-05,TRUE,3797,112,45,GO:BP,positive regulation of metabolic process,21010,3811,GO:0008152|GO:0019222|GO:0048518,FALSE
GO:0032787,6.04706482735596e-05,TRUE,625,112,17,GO:BP,monocarboxylic acid metabolic process,21010,8193,GO:0019752,FALSE
GO:0032101,6.4225591395184e-05,TRUE,1062,112,22,GO:BP,regulation of response to external stimulus,21010,7724,GO:0009605|GO:0048583,FALSE
GO:0010874,7.0235371792697e-05,TRUE,37,112,6,GO:BP,regulation of cholesterol efflux,21010,4543,GO:0032374|GO:0033344,FALSE
GO:0030100,7.02447230133759e-05,TRUE,285,112,12,GO:BP,regulation of endocytosis,21010,6993,GO:0006897|GO:0051128|GO:0060627,FALSE
GO:0031325,7.30047825910164e-05,TRUE,3407,112,42,GO:BP,positive regulation of cellular metabolic process,21010,7463,GO:0009893|GO:0031323|GO:0044237|GO:0048522,FALSE
GO:0120020,7.31866042743587e-05,TRUE,23,108,5,GO:MF,cholesterol transfer activity,20139,10440,GO:0120015,TRUE
KEGG:05140,7.56329208220933e-05,TRUE,72,88,8,KEGG,Leishmaniasis,8161,426,KEGG:00000,FALSE
GO:0019318,7.63868235125657e-05,TRUE,231,112,11,GO:BP,hexose metabolic process,21010,5938,GO:0005996,FALSE
GO:0008203,7.72797817149457e-05,TRUE,135,112,9,GO:BP,cholesterol metabolic process,21010,3183,GO:0016125|GO:1902652,FALSE
GO:0050794,8.09816481444031e-05,TRUE,11758,112,90,GO:BP,regulation of cellular process,21010,13920,GO:0009987|GO:0050789,FALSE
GO:0015433,8.72039069913955e-05,TRUE,3,108,3,GO:MF,ABC-type peptide antigen transporter activity,20139,2555,GO:0015440,TRUE
GO:0062061,8.72039069913955e-05,TRUE,3,108,3,GO:MF,TAP complex binding,20139,8594,GO:0044877,FALSE
GO:0046979,8.72039069913955e-05,TRUE,3,108,3,GO:MF,TAP2 binding,20139,6313,GO:0046977,FALSE
GO:0070653,8.72039069913955e-05,TRUE,3,108,3,GO:MF,high-density lipoprotein particle receptor binding,20139,8765,GO:0070325,FALSE
GO:0015031,8.81658046494334e-05,TRUE,1810,112,29,GO:BP,protein transport,21010,4880,GO:0045184|GO:0071702|GO:0071705,FALSE
GO:0045184,9.00316478018996e-05,TRUE,1925,112,30,GO:BP,establishment of protein localization,21010,11918,GO:0008104|GO:0051234,FALSE
GO:0002831,9.03765243385498e-05,TRUE,490,112,15,GO:BP,regulation of response to biotic stimulus,21010,1355,GO:0009607|GO:0048583,FALSE
GO:0032489,9.0843015157223e-05,TRUE,8,112,4,GO:BP,regulation of Cdc42 protein signal transduction,21010,7964,GO:0032488|GO:0035023,TRUE
GO:0002767,9.0843015157223e-05,TRUE,8,112,4,GO:BP,immune response-inhibiting cell surface receptor signaling pathway,21010,1292,GO:0002765|GO:0002768,TRUE
GO:0061365,9.0843015157223e-05,TRUE,8,112,4,GO:BP,positive regulation of triglyceride lipase activity,21010,16210,GO:0060193,FALSE
GO:0120015,9.2052702848485e-05,TRUE,24,108,5,GO:MF,sterol transfer activity,20139,10436,GO:0015248|GO:0120013,FALSE
GO:0000041,9.99258698969897e-05,TRUE,99,112,8,GO:BP,transition metal ion transport,21010,17,GO:0030001,FALSE
KEGG:03320,0.000103845001631194,TRUE,75,88,8,KEGG,PPAR signaling pathway,8161,231,KEGG:00000,FALSE
KEGG:05168,0.00010631545556956,TRUE,505,88,19,KEGG,Herpes simplex virus 1 infection,8161,442,KEGG:00000,FALSE
GO:0015026,0.000107951927269033,TRUE,47,108,6,GO:MF,coreceptor activity,20139,2282,GO:0038023,TRUE
GO:0032102,0.00011905602892281,TRUE,429,112,14,GO:BP,negative regulation of response to external stimulus,21010,7725,GO:0009605|GO:0032101|GO:0048585,FALSE
GO:0002832,0.000119720691253528,TRUE,142,112,9,GO:BP,negative regulation of response to biotic stimulus,21010,1356,GO:0002831|GO:0009607|GO:0048585,FALSE
GO:0002700,0.00012058006687842,TRUE,189,112,10,GO:BP,regulation of production of molecular mediator of immune response,21010,1232,GO:0002440|GO:0002697|GO:0010468,FALSE
GO:0030141,0.000126954306892622,TRUE,871,112,18,GO:CC,secretory granule,22090,919,GO:0012505|GO:0099503,FALSE
GO:0030665,0.000129216113252028,TRUE,133,112,8,GO:CC,clathrin-coated vesicle membrane,22090,956,GO:0030136|GO:0030662,FALSE
GO:0065007,0.000131761473295693,TRUE,12751,112,94,GO:BP,biological regulation,21010,16682,GO:0008150,FALSE
GO:1990000,0.000133511469038918,TRUE,41,112,6,GO:BP,amyloid fibril formation,21010,26092,GO:0019538|GO:0097435,TRUE
GO:0062013,0.000135079283454991,TRUE,144,112,9,GO:BP,positive regulation of small molecule metabolic process,21010,16574,GO:0009893|GO:0044281|GO:0062012,FALSE
GO:0031984,0.000138537432456994,TRUE,1505,112,24,GO:CC,organelle subcompartment,22090,1233,GO:0043227|GO:0043229|GO:0110165,FALSE
GO:0044283,0.000140776667819603,TRUE,583,112,16,GO:BP,small molecule biosynthetic process,21010,11508,GO:0009058|GO:0044281,FALSE
GO:0034362,0.000142172288403637,TRUE,13,112,4,GO:CC,low-density lipoprotein particle,22090,1474,GO:0034358,FALSE
GO:1902652,0.000143382994539564,TRUE,145,112,9,GO:BP,secondary alcohol metabolic process,21010,23325,GO:0006066,FALSE
HPA:0471443,0.000144101030872494,TRUE,467,67,14,HPA,skin 2; fibrohistiocytic cells[High],11006,706,HPA:0471442,FALSE
GO:0042608,0.000145775010369283,TRUE,11,108,4,GO:MF,T cell receptor binding,20139,5658,GO:0005102|GO:0044877,FALSE
GO:1904680,0.000145775010369283,TRUE,11,108,4,GO:MF,peptide transmembrane transporter activity,20139,11035,GO:0042887,FALSE
GO:0008035,0.000145775010369283,TRUE,11,108,4,GO:MF,high-density lipoprotein particle binding,20139,1532,GO:0071813,FALSE
GO:0050777,0.000146809527053603,TRUE,193,112,10,GO:BP,negative regulation of immune response,21010,13909,GO:0002683|GO:0006955|GO:0048585|GO:0050776,FALSE
HP:0010979,0.000147937150458025,TRUE,56,54,8,HP,Abnormality of lipoprotein cholesterol concentration,4962,7401,HP:0003107,FALSE
GO:0006066,0.000154559148218726,TRUE,370,112,13,GO:BP,alcohol metabolic process,21010,1961,GO:0044281|GO:1901615,FALSE
GO:0002578,0.000162845219111661,TRUE,9,112,4,GO:BP,negative regulation of antigen processing and presentation,21010,1113,GO:0002577|GO:0002683|GO:0019882,FALSE
GO:0071281,0.000162845219111661,TRUE,9,112,4,GO:BP,cellular response to iron ion,21010,17347,GO:0010039|GO:0071248,FALSE
GO:0016485,0.000163891452961945,TRUE,249,112,11,GO:BP,protein processing,21010,5322,GO:0006508|GO:0051604,FALSE
GO:0048585,0.000164073962674774,TRUE,1639,112,27,GO:BP,negative regulation of response to stimulus,21010,13508,GO:0048519|GO:0048583|GO:0050896,FALSE
GO:1903440,0.000166334181470014,TRUE,4,112,3,GO:CC,amylin receptor complex,22090,3683,GO:1903439,FALSE
GO:0034363,0.000166334181470014,TRUE,4,112,3,GO:CC,intermediate-density lipoprotein particle,22090,1475,GO:0034385,FALSE
REAC:R-HSA-70263,0.000168003454634596,TRUE,32,100,6,REAC,Gluconeogenesis,10835,1005,REAC:R-HSA-70326,FALSE
GO:0031347,0.000171712905013092,TRUE,756,112,18,GO:BP,regulation of defense response,21010,7484,GO:0006952|GO:0080134,FALSE
GO:0080134,0.000177325743435532,TRUE,1430,112,25,GO:BP,regulation of response to stress,21010,18659,GO:0006950|GO:0048583,FALSE
GO:0032814,0.000179462387706522,TRUE,43,112,6,GO:BP,regulation of natural killer cell activation,21010,8209,GO:0030101|GO:0051249,FALSE
GO:0016125,0.000191930810010719,TRUE,150,112,9,GO:BP,sterol metabolic process,21010,5230,GO:0008202|GO:1901615,FALSE
GO:0048731,0.000204044108022499,TRUE,3951,112,45,GO:BP,system development,21010,13640,GO:0007275|GO:0048856,FALSE
GO:0023051,0.000208946126169609,TRUE,3396,112,41,GO:BP,regulation of signaling,21010,6954,GO:0023052|GO:0050789,FALSE
GO:0048259,0.000212187589407112,TRUE,109,112,8,GO:BP,regulation of receptor-mediated endocytosis,21010,13260,GO:0006898|GO:0030100,FALSE
GO:0010646,0.000225051720665707,TRUE,3405,112,41,GO:BP,regulation of cell communication,21010,4364,GO:0007154|GO:0050794,FALSE
REAC:R-HSA-8957275,0.000242877328615551,TRUE,107,100,9,REAC,Post-translational protein phosphorylation,10835,1696,REAC:R-HSA-597592,FALSE
GO:0005996,0.000253561206612907,TRUE,260,112,11,GO:BP,monosaccharide metabolic process,21010,1893,GO:0005975|GO:0044281,FALSE
GO:0045807,0.000254214842714146,TRUE,155,112,9,GO:BP,positive regulation of endocytosis,21010,12246,GO:0006897|GO:0030100|GO:0051050|GO:0051130,FALSE
GO:0034441,0.000254266737613312,TRUE,3,112,3,GO:BP,plasma lipoprotein particle oxidation,21010,9034,GO:0034369,FALSE
GO:0034371,0.000254266737613312,TRUE,3,112,3,GO:BP,chylomicron remodeling,21010,8988,GO:0034370,FALSE
GO:0060205,0.000255981891430439,TRUE,323,112,11,GO:CC,cytoplasmic vesicle lumen,22090,2291,GO:0031410|GO:0031983|GO:0070013,FALSE
GO:0031983,0.000263863816567011,TRUE,324,112,11,GO:CC,vesicle lumen,22090,1232,GO:0031982|GO:0043233,FALSE
GO:0002765,0.000270293105918485,TRUE,10,112,4,GO:BP,immune response-inhibiting signal transduction,21010,1290,GO:0002764,FALSE
GO:0046470,0.000281801377515701,TRUE,76,112,7,GO:BP,phosphatidylcholine metabolic process,21010,12802,GO:0006650|GO:1901564,TRUE
HPA:0481301,0.00029242819126618,TRUE,572,67,15,HPA,small intestine; enterocytes[Low],11006,729,HPA:0480000,FALSE
GO:0031210,0.000300834020510206,TRUE,30,108,5,GO:MF,phosphatidylcholine binding,20139,4126,GO:0005543|GO:0043169|GO:0050997,TRUE
GO:0000139,0.000312188175676416,TRUE,646,112,15,GO:CC,Golgi membrane,22090,18,GO:0005794|GO:0098588,FALSE
GO:0007154,0.000319921343396764,TRUE,6495,112,61,GO:BP,cell communication,21010,2765,GO:0009987,FALSE
KEGG:05150,0.000323798294201933,TRUE,87,88,8,KEGG,Staphylococcus aureus infection,8161,432,KEGG:00000,FALSE
GO:0007166,0.000324785906161421,TRUE,2783,112,36,GO:BP,cell surface receptor signaling pathway,21010,2777,GO:0007165,FALSE
GO:0006007,0.000331017327999799,TRUE,25,112,5,GO:BP,glucose catabolic process,21010,1904,GO:0006006|GO:0019320,FALSE
GO:0060586,0.000331017327999799,TRUE,25,112,5,GO:BP,multicellular organismal-level iron ion homeostasis,21010,15505,GO:0055080|GO:0098771|GO:0140962,TRUE
GO:0042802,0.000331568076162304,TRUE,2143,108,30,GO:MF,identical protein binding,20139,5676,GO:0005515,FALSE
GO:0097643,0.000347451442888988,TRUE,4,108,3,GO:MF,amylin receptor activity,20139,9195,GO:0097642,TRUE
GO:0060230,0.000347451442888988,TRUE,4,108,3,GO:MF,lipoprotein lipase activator activity,20139,8453,GO:0060229,TRUE
GO:0007275,0.000350989761834928,TRUE,4610,112,49,GO:BP,multicellular organism development,21010,2853,GO:0032501|GO:0048856,FALSE
REAC:R-HSA-8964058,0.00035202299595087,TRUE,9,100,4,REAC,HDL remodeling,10835,1044,REAC:R-HSA-8963899,FALSE
KEGG:05323,0.00035307342404737,TRUE,88,88,8,KEGG,Rheumatoid arthritis,8161,478,KEGG:00000,FALSE
GO:0071705,0.00036485857024498,TRUE,2292,112,32,GO:BP,nitrogen compound transport,21010,17687,GO:0006810,FALSE
KEGG:04658,0.000384563328562498,TRUE,89,88,8,KEGG,Th1 and Th2 cell differentiation,8161,330,KEGG:00000,FALSE
HPA:0131332,0.000393717267290156,TRUE,365,67,12,HPA,colon; mucosal lymphoid cells[Medium],11006,238,HPA:0131331,FALSE
GO:0019433,0.000408094097865893,TRUE,26,112,5,GO:BP,triglyceride catabolic process,21010,6048,GO:0006641|GO:0046464,FALSE
GO:0010875,0.000408094097865893,TRUE,26,112,5,GO:BP,positive regulation of cholesterol efflux,21010,4544,GO:0010874|GO:0032376|GO:0033344,FALSE
GO:1903439,0.000414296658963329,TRUE,5,112,3,GO:CC,calcitonin family receptor complex,22090,3682,GO:0097648,FALSE
GO:0010628,0.00042034441722256,TRUE,1183,112,22,GO:BP,positive regulation of gene expression,21010,4346,GO:0010467|GO:0010468|GO:0010557,FALSE
GO:0030136,0.000466059650013397,TRUE,213,112,9,GO:CC,clathrin-coated vesicle,22090,915,GO:0030135,FALSE
GO:0023052,0.0004797990922395,TRUE,6396,112,60,GO:BP,signaling,21010,6955,GO:0050789,FALSE
WP:WP5362,0.000485784699218959,TRUE,63,87,7,WP,TAR syndrome,8625,782,WP:000000,FALSE
GO:0045954,0.000498720343050227,TRUE,27,112,5,GO:BP,positive regulation of natural killer cell mediated cytotoxicity,21010,12363,GO:0001912|GO:0002717|GO:0042267|GO:0042269,FALSE
GO:0098542,0.000506700033201199,TRUE,1196,112,22,GO:BP,defense response to other organism,21010,19686,GO:0006952|GO:0051707,FALSE
GO:0002440,0.000518189242241081,TRUE,221,112,10,GO:BP,production of molecular mediator of immune response,21010,977,GO:0002376|GO:0010467,FALSE
GO:0019216,0.000538836510205965,TRUE,344,112,12,GO:BP,regulation of lipid metabolic process,21010,5849,GO:0006629|GO:0080090,FALSE
GO:0044255,0.000540918686317899,TRUE,1003,112,20,GO:BP,cellular lipid metabolic process,21010,11496,GO:0006629|GO:0044237,FALSE
GO:1901615,0.000553898282432557,TRUE,564,112,15,GO:BP,organic hydroxy compound metabolic process,21010,22472,GO:0071704,FALSE
GO:0051241,0.000553905057650709,TRUE,1102,112,21,GO:BP,negative regulation of multicellular organismal process,21010,14272,GO:0032501|GO:0048519|GO:0051239,FALSE
KEGG:00010,0.000574247843830452,TRUE,67,88,7,KEGG,Glycolysis / Gluconeogenesis,8161,2,KEGG:00000,FALSE
GO:0005041,0.000593084831202354,TRUE,15,108,4,GO:MF,low-density lipoprotein particle receptor activity,20139,1258,GO:0030228,FALSE
GO:0055102,0.000593084831202354,TRUE,15,108,4,GO:MF,lipase inhibitor activity,20139,8438,GO:0004857,TRUE
GO:0002710,0.000604565166397156,TRUE,28,112,5,GO:BP,negative regulation of T cell mediated immunity,21010,1242,GO:0002456|GO:0002707|GO:0002709|GO:0002823,FALSE
GO:0006954,0.000612150003761408,TRUE,824,112,18,GO:BP,inflammatory response,21010,2627,GO:0006952,FALSE
GO:0010557,0.00062824441496399,TRUE,2599,112,34,GO:BP,positive regulation of macromolecule biosynthetic process,21010,4281,GO:0009059|GO:0010556|GO:0010604|GO:0031328,FALSE
REAC:R-HSA-913531,0.000649913180719878,TRUE,193,100,11,REAC,Interferon Signaling,10835,1175,REAC:R-HSA-1280215,FALSE
GO:0005737,0.000699248977701896,TRUE,12251,112,86,GO:CC,cytoplasm,22090,309,GO:0005622|GO:0110165,FALSE
GO:0042221,0.00071299291774256,TRUE,3975,112,44,GO:BP,response to chemical,21010,10548,GO:0050896,FALSE
GO:0046890,0.000713018928692913,TRUE,175,112,9,GO:BP,regulation of lipid biosynthetic process,21010,13058,GO:0008610|GO:0009889|GO:0019216,FALSE
REAC:R-HSA-381426,0.00084476558126366,TRUE,124,100,9,REAC,Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs),10835,1897,REAC:R-HSA-392499,FALSE
WP:WP2878,0.000862887885321436,TRUE,26,87,5,WP,PPAR-alpha pathway,8625,216,WP:000000,FALSE
GO:0015440,0.000865232236932073,TRUE,5,108,3,GO:MF,ABC-type peptide transporter activity,20139,2561,GO:0140359|GO:1904680,FALSE
GO:0015248,0.00089314011042613,TRUE,37,108,5,GO:MF,sterol transporter activity,20139,2445,GO:0005319,FALSE
GO:0010896,0.000908985114635053,TRUE,13,112,4,GO:BP,regulation of triglyceride catabolic process,21010,4565,GO:0019433|GO:0031329|GO:0050994|GO:0090207,FALSE
GO:0042129,0.000947124089946146,TRUE,181,112,9,GO:BP,regulation of T cell proliferation,21010,10479,GO:0042098|GO:0050670|GO:0050863,FALSE
GO:0010916,0.00101310897343608,TRUE,4,112,3,GO:BP,negative regulation of very-low-density lipoprotein particle clearance,21010,4585,GO:0010915|GO:0010985|GO:0034447,FALSE
GO:0002397,0.00101310897343608,TRUE,4,112,3,GO:BP,MHC class I protein complex assembly,21010,935,GO:0002396,FALSE
GO:0002584,0.00101310897343608,TRUE,4,112,3,GO:BP,negative regulation of antigen processing and presentation of peptide antigen,21010,1119,GO:0002578|GO:0002583|GO:0048002,FALSE
GO:1990410,0.00101310897343608,TRUE,4,112,3,GO:BP,adrenomedullin receptor signaling pathway,21010,26210,GO:0097646,FALSE
GO:0010903,0.00101310897343608,TRUE,4,112,3,GO:BP,negative regulation of very-low-density lipoprotein particle remodeling,21010,4572,GO:0010901|GO:0034372|GO:0051129|GO:0051241,FALSE
GO:0010915,0.00101310897343608,TRUE,4,112,3,GO:BP,regulation of very-low-density lipoprotein particle clearance,21010,4584,GO:0010984|GO:0034447,FALSE
GO:0002502,0.00101310897343608,TRUE,4,112,3,GO:BP,peptide antigen assembly with MHC class I protein complex,21010,1039,GO:0002397|GO:0002474|GO:0002501,FALSE
GO:0045087,0.00101477266687322,TRUE,947,112,19,GO:BP,innate immune response,21010,11875,GO:0006955|GO:0098542,FALSE
GO:0005515,0.0011120055358613,TRUE,14811,108,99,GO:MF,protein binding,20139,1495,GO:0005488,FALSE
GO:0098802,0.0011348899567441,TRUE,304,112,10,GO:CC,plasma membrane signaling receptor complex,22090,3270,GO:0043235|GO:0098797,FALSE
GO:0001817,0.00114036279781805,TRUE,769,112,17,GO:BP,regulation of cytokine production,21010,484,GO:0001816|GO:0010468|GO:0051239,FALSE
GO:0008289,0.00116808696167106,TRUE,831,108,17,GO:MF,lipid binding,20139,1646,GO:0005488,FALSE
KEGG:05170,0.0011899254328624,TRUE,210,88,11,KEGG,Human immunodeficiency virus 1 infection,8161,444,KEGG:00000,FALSE
GO:0140534,0.00120515805449728,TRUE,126,112,7,GO:CC,endoplasmic reticulum protein-containing complex,22090,3567,GO:0005783|GO:0032991,FALSE
GO:0010604,0.00124410302958586,TRUE,3483,112,40,GO:BP,positive regulation of macromolecule metabolic process,21010,4323,GO:0009893|GO:0043170|GO:0060255,FALSE
HPA:0461443,0.00124700706677956,TRUE,408,67,12,HPA,skin 1; fibrohistiocytic cells[High],11006,654,HPA:0461442,FALSE
GO:0001816,0.00126945903890274,TRUE,775,112,17,GO:BP,cytokine production,21010,483,GO:0010467|GO:0032501,FALSE
GO:0060627,0.00128031428377894,TRUE,522,112,14,GO:BP,regulation of vesicle-mediated transport,21010,15542,GO:0016192|GO:0050794|GO:0051049,FALSE
GO:0030228,0.00131316525415757,TRUE,18,108,4,GO:MF,lipoprotein particle receptor activity,20139,3878,GO:0038024,FALSE
HP:0001114,0.00131453206076151,TRUE,18,54,5,HP,Xanthelasma,4962,873,HP:0000991|HP:0010732,FALSE
GO:0042592,0.00131802035127002,TRUE,1704,112,26,GO:BP,homeostatic process,21010,10755,GO:0008150,FALSE
KEGG:04659,0.00131979046919942,TRUE,105,88,8,KEGG,Th17 cell differentiation,8161,331,KEGG:00000,FALSE
GO:0048519,0.00135093805565051,TRUE,5913,112,56,GO:BP,negative regulation of biological process,21010,13452,GO:0008150|GO:0050789,FALSE
REAC:R-HSA-9024446,0.00137068107501205,TRUE,45,100,6,REAC,NR1H2 and NR1H3-mediated signaling,10835,1469,REAC:R-HSA-9006931,FALSE
GO:0031326,0.0013976397880626,TRUE,5757,112,55,GO:BP,regulation of cellular biosynthetic process,21010,7464,GO:0009889|GO:0031323|GO:0044249,FALSE
GO:0002768,0.00165156916966775,TRUE,314,112,11,GO:BP,immune response-regulating cell surface receptor signaling pathway,21010,1293,GO:0002764|GO:0007166,FALSE
GO:0050994,0.00166687831554704,TRUE,62,112,6,GO:BP,regulation of lipid catabolic process,21010,14098,GO:0009894|GO:0016042|GO:0019216,FALSE
GO:0044093,0.00167367558729674,TRUE,1500,112,24,GO:BP,positive regulation of molecular function,21010,11466,GO:0065009,FALSE
GO:0009889,0.00169156817556015,TRUE,5789,112,55,GO:BP,regulation of biosynthetic process,21010,3807,GO:0009058|GO:0019222,FALSE
GO:0032394,0.0017236997979308,TRUE,6,108,3,GO:MF,MHC class Ib receptor activity,20139,4447,GO:0004888|GO:0140375,TRUE
GO:0097642,0.0017236997979308,TRUE,6,108,3,GO:MF,calcitonin family receptor activity,20139,9194,GO:0008528,FALSE
WP:WP5115,0.00172917241200895,TRUE,217,87,11,WP,Network map of SARS-CoV-2 signaling pathway,8625,25,WP:000000,FALSE
KEGG:05145,0.00173643685009335,TRUE,109,88,8,KEGG,Toxoplasmosis,8161,430,KEGG:00000,FALSE
GO:0140352,0.0017751413645135,TRUE,887,112,18,GO:BP,export from cell,21010,20673,GO:0006810|GO:0009987,FALSE
GO:0002521,0.00178538450392105,TRUE,619,112,15,GO:BP,leukocyte differentiation,21010,1057,GO:0030097|GO:0030154,FALSE
GO:0034774,0.00178540317454055,TRUE,320,112,10,GO:CC,secretory granule lumen,22090,1570,GO:0030141|GO:0060205,FALSE
GO:0031901,0.00188479314330745,TRUE,190,112,8,GO:CC,early endosome membrane,22090,1199,GO:0005769|GO:0010008,FALSE
GO:0008104,0.00195048522803207,TRUE,2728,112,34,GO:BP,protein localization,21010,3176,GO:0070727,FALSE
KEGG:00051,0.00203709499267945,TRUE,33,88,5,KEGG,Fructose and mannose metabolism,8161,6,KEGG:00000,FALSE
HP:0025201,0.00204972824781887,TRUE,9,54,4,HP,Abnormal circulating apolipoprotein concentration,4962,9640,HP:0010876,FALSE
KEGG:05163,0.00208823264813779,TRUE,223,88,11,KEGG,Human cytomegalovirus infection,8161,437,KEGG:00000,FALSE
GO:0070727,0.00212222304293011,TRUE,2738,112,34,GO:BP,cellular macromolecule localization,21010,17079,GO:0033036|GO:0051641,FALSE
HPA:0131331,0.00219017024987755,TRUE,508,67,13,HPA,colon; mucosal lymphoid cells[Low],11006,237,HPA:0130000,FALSE
GO:0042102,0.00226953970725115,TRUE,103,112,7,GO:BP,positive regulation of T cell proliferation,21010,10463,GO:0042098|GO:0042129|GO:0050671|GO:0050870,FALSE
GO:1905906,0.00228538480297301,TRUE,16,112,4,GO:BP,regulation of amyloid fibril formation,21010,26044,GO:0051246|GO:1902903|GO:1990000,FALSE
HP:0010732,0.00233968546339234,TRUE,20,54,5,HP,Nodular changes affecting the eyelids,4962,7165,HP:0000492|HP:0200036,FALSE
GO:1905908,0.00252291819003976,TRUE,5,112,3,GO:BP,positive regulation of amyloid fibril formation,21010,26046,GO:0051247|GO:1902905|GO:1905906|GO:1990000,FALSE
GO:0032373,0.00258090156305895,TRUE,37,112,5,GO:BP,positive regulation of sterol transport,21010,7891,GO:0015918|GO:0032370|GO:0032371,FALSE
GO:0032376,0.00258090156305895,TRUE,37,112,5,GO:BP,positive regulation of cholesterol transport,21010,7894,GO:0030301|GO:0032373|GO:0032374,FALSE
GO:0048856,0.00259594301345413,TRUE,5862,112,55,GO:BP,anatomical structure development,21010,13752,GO:0032502,FALSE
WP:WP5109,0.00267089943765262,TRUE,16,87,4,WP,Familial hyperlipidemia type 2,8625,346,WP:000000,FALSE
GO:0045833,0.00275510722107039,TRUE,106,112,7,GO:BP,negative regulation of lipid metabolic process,21010,12266,GO:0006629|GO:0009892|GO:0019216,FALSE
GO:0045088,0.00278091458909719,TRUE,402,112,12,GO:BP,regulation of innate immune response,21010,11876,GO:0002831|GO:0031347|GO:0032101|GO:0045087|GO:0050776,FALSE
GO:0032940,0.00279336874499967,TRUE,821,112,17,GO:BP,secretion by cell,21010,8298,GO:0046903|GO:0140352,FALSE
GO:0045834,0.00284514570976348,TRUE,153,112,8,GO:BP,positive regulation of lipid metabolic process,21010,12267,GO:0006629|GO:0009893|GO:0019216,FALSE
GO:0051716,0.00292347825813055,TRUE,7399,112,64,GO:BP,cellular response to stimulus,21010,14605,GO:0009987|GO:0050896,FALSE
GO:1905954,0.00293510845143318,TRUE,107,112,7,GO:BP,positive regulation of lipid localization,21010,26084,GO:0010876|GO:0048518|GO:1905952,FALSE
GO:0032488,0.00297630745447998,TRUE,17,112,4,GO:BP,Cdc42 protein signal transduction,21010,7963,GO:0007266,FALSE
REAC:R-HSA-382551,0.00300334859391964,TRUE,718,100,20,REAC,Transport of small molecules,10835,2481,REAC:0000000,FALSE
HP:0001681,0.00303182025612315,TRUE,37,54,6,HP,Angina pectoris,4962,1223,HP:0011025,FALSE
GO:0065009,0.00319616855480127,TRUE,2526,112,32,GO:BP,regulation of molecular function,21010,16684,GO:0065007,FALSE
HP:0002621,0.00328094109718358,TRUE,83,54,8,HP,Atherosclerosis,4962,1896,HP:0002634,FALSE
GO:0032991,0.00333232800350968,TRUE,8527,112,66,GO:CC,protein-containing complex,22090,1343,GO:0005575,FALSE
GO:0097648,0.00342889199006999,TRUE,9,112,3,GO:CC,G protein-coupled receptor complex,22090,3113,GO:0098802,FALSE
GO:0042098,0.00366995711825932,TRUE,213,112,9,GO:BP,T cell proliferation,21010,10461,GO:0042110|GO:0046651,FALSE
GO:0042803,0.00374547943927862,TRUE,716,108,15,GO:MF,protein homodimerization activity,20139,5677,GO:0042802|GO:0046983,FALSE
GO:0006735,0.00381096877969822,TRUE,18,112,4,GO:BP,NADH regeneration,21010,2475,GO:0008152,FALSE
GO:0061718,0.00381096877969822,TRUE,18,112,4,GO:BP,glucose catabolic process to pyruvate,21010,16413,GO:0006007|GO:0006090,FALSE
GO:0061621,0.00381096877969822,TRUE,18,112,4,GO:BP,canonical glycolysis,21010,16373,GO:0006735|GO:0061620|GO:0061718,FALSE
HPA:0151301,0.00412503036315738,TRUE,539,67,13,HPA,duodenum; enterocytes[Low],11006,260,HPA:0150000,FALSE
GO:0009719,0.00422278484777119,TRUE,1696,112,25,GO:BP,response to endogenous stimulus,21010,3674,GO:0050896,FALSE
GO:0070887,0.00428158871166227,TRUE,2691,112,33,GO:BP,cellular response to chemical stimulus,21010,17162,GO:0042221|GO:0051716,FALSE
GO:0090207,0.00436245193841906,TRUE,41,112,5,GO:BP,regulation of triglyceride metabolic process,21010,18967,GO:0006641|GO:0019216|GO:0031323,FALSE
GO:0015485,0.00453457563619674,TRUE,51,108,5,GO:MF,cholesterol binding,20139,2583,GO:0032934|GO:0043178,FALSE
GO:0019752,0.00455267514397372,TRUE,948,112,18,GO:BP,carboxylic acid metabolic process,21010,6321,GO:0043436,FALSE
GO:0016052,0.00457086097552746,TRUE,163,112,8,GO:BP,carbohydrate catabolic process,21010,5170,GO:0005975|GO:1901575,FALSE
HP:0010980,0.00488212620315608,TRUE,40,54,6,HP,Hyperlipoproteinemia,4962,7402,HP:0010979,FALSE
REAC:R-HSA-70326,0.00495533419988165,TRUE,84,100,7,REAC,Glucose metabolism,10835,1006,REAC:R-HSA-71387,FALSE
GO:0002583,0.00502620894542741,TRUE,6,112,3,GO:BP,regulation of antigen processing and presentation of peptide antigen,21010,1118,GO:0002577|GO:0048002,FALSE
GO:0030425,0.00528104301365458,TRUE,621,112,13,GO:CC,dendrite,22090,936,GO:0043005|GO:0097447,TRUE
GO:0097447,0.00546248730096925,TRUE,623,112,13,GO:CC,dendritic tree,22090,3012,GO:0036477|GO:0043005,FALSE
GO:0019320,0.00555621845004085,TRUE,43,112,5,GO:BP,hexose catabolic process,21010,5940,GO:0019318|GO:0046365,FALSE
REAC:R-HSA-917937,0.00558507979832497,TRUE,57,100,6,REAC,Iron uptake and transport,10835,1225,REAC:R-HSA-382551,FALSE
HP:0002634,0.00558819293461174,TRUE,89,54,8,HP,Arteriosclerosis,4962,1906,HP:0011004,FALSE
GO:0005543,0.00562186296911074,TRUE,477,108,12,GO:MF,phospholipid binding,20139,1513,GO:0008289,FALSE
WP:WP5355,0.00565899010986087,TRUE,91,87,7,WP,Metabolic Epileptic Disorders,8625,571,WP:000000,FALSE
GO:0044242,0.00575278862175034,TRUE,225,112,9,GO:BP,cellular lipid catabolic process,21010,11491,GO:0016042|GO:0044248|GO:0044255,FALSE
HPA:0401332,0.00575471942186486,TRUE,398,67,11,HPA,rectum; mucosal lymphoid cells[Medium],11006,569,HPA:0401331,FALSE
WP:WP183,0.00576834731786647,TRUE,62,87,6,WP,Proteasome degradation,8625,111,WP:000000,FALSE
GO:0051051,0.00584247634637375,TRUE,432,112,12,GO:BP,negative regulation of transport,21010,14133,GO:0006810|GO:0048519|GO:0051049,FALSE
GO:0061620,0.00598459452224005,TRUE,20,112,4,GO:BP,glycolytic process through glucose-6-phosphate,21010,16372,GO:0061615,FALSE
KEGG:04216,0.00601047344649656,TRUE,41,88,5,KEGG,Ferroptosis,8161,287,KEGG:00000,FALSE
GO:0120013,0.00602739911810853,TRUE,54,108,5,GO:MF,lipid transfer activity,20139,10434,GO:0005319,FALSE
GO:0050997,0.00602739911810853,TRUE,54,108,5,GO:MF,quaternary ammonium group binding,20139,7977,GO:0005488,FALSE
KEGG:05322,0.00617759186149901,TRUE,130,88,8,KEGG,Systemic lupus erythematosus,8161,477,KEGG:00000,FALSE
HP:0031888,0.00620569828796453,TRUE,24,54,5,HP,Abnormal HDL cholesterol concentration,4962,11927,HP:0010979,FALSE
GO:0043436,0.00627214620821762,TRUE,970,112,18,GO:BP,oxoacid metabolic process,21010,11204,GO:0006082,FALSE
HP:0000873,0.00631462493946623,TRUE,64,54,7,HP,Diabetes insipidus,4962,682,HP:0000818,FALSE
GO:0010038,0.00636656193238628,TRUE,361,112,11,GO:BP,response to metal ion,21010,3908,GO:0010035,FALSE
GO:0038023,0.00650320547335738,TRUE,1488,108,22,GO:MF,signaling receptor activity,20139,5536,GO:0060089,FALSE
GO:0060089,0.00650320547335738,TRUE,1488,108,22,GO:MF,molecular transducer activity,20139,8447,GO:0003674,FALSE
HP:0033459,0.00653778710262397,TRUE,4,54,3,HP,Decreased circulating apolipoprotein concentration,4962,13443,HP:0025201,FALSE
HP:0031887,0.00653778710262397,TRUE,4,54,3,HP,Abnormal chylomicron concentration,4962,11926,HP:0010979,FALSE
HP:0012238,0.00653778710262397,TRUE,4,54,3,HP,Increased circulating chylomicron concentration,4962,8632,HP:0010980|HP:0031887,FALSE
HP:0011025,0.00673684133672013,TRUE,1389,54,31,HP,Abnormal cardiovascular system physiology,4962,7443,HP:0001626,FALSE
GO:0006082,0.00683350352463606,TRUE,976,112,18,GO:BP,organic acid metabolic process,21010,1976,GO:0044237|GO:0044281|GO:0071704,FALSE
REAC:R-HSA-168256,0.00687483493765273,TRUE,2051,100,37,REAC,Immune System,10835,1118,REAC:0000000,FALSE
GO:0042304,0.00699256917098246,TRUE,45,112,5,GO:BP,regulation of fatty acid biosynthetic process,21010,10577,GO:0006633|GO:0019217|GO:0031326|GO:0046890,FALSE
GO:0009306,0.00707272970554192,TRUE,365,112,11,GO:BP,protein secretion,21010,3508,GO:0015031|GO:0032940|GO:0035592,FALSE
REAC:R-HSA-2132295,0.0072330774512974,TRUE,123,100,8,REAC,MHC class II antigen presentation,10835,1312,REAC:R-HSA-1280218,FALSE
GO:0035592,0.00725963647693901,TRUE,366,112,11,GO:BP,establishment of protein localization to extracellular region,21010,9549,GO:0045184|GO:0071692,FALSE
GO:0002577,0.00736239239124884,TRUE,21,112,4,GO:BP,regulation of antigen processing and presentation,21010,1112,GO:0002682|GO:0019882,FALSE
REAC:R-HSA-9029569,0.00770913139877499,TRUE,36,100,5,REAC,NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux,10835,1470,REAC:R-HSA-9024446,FALSE
REAC:R-HSA-8964043,0.00770913139877499,TRUE,36,100,5,REAC,Plasma lipoprotein clearance,10835,1676,REAC:R-HSA-174824,FALSE
REAC:R-HSA-8963889,0.00801980793350452,TRUE,18,100,4,REAC,Assembly of active LPL and LIPC lipase complexes,10835,170,REAC:R-HSA-8963899,FALSE
GO:0002720,0.00810637390083405,TRUE,81,112,6,GO:BP,positive regulation of cytokine production involved in immune response,21010,1252,GO:0001819|GO:0002367|GO:0002702|GO:0002718,FALSE
GO:0032398,0.00838099625860353,TRUE,2,112,2,GO:CC,MHC class Ib protein complex,22090,1298,GO:0042611,FALSE
GO:0034365,0.00838099625860353,TRUE,2,112,2,GO:CC,discoidal high-density lipoprotein particle,22090,1477,GO:0034364,FALSE
GO:0061779,0.00838099625860353,TRUE,2,112,2,GO:CC,Tapasin-ERp57 complex,22090,2332,GO:0042824|GO:0098796|GO:0140534,FALSE
GO:0010035,0.00868711329837518,TRUE,530,112,13,GO:BP,response to inorganic substance,21010,3905,GO:0042221,FALSE
GO:0071692,0.00869348538775987,TRUE,373,112,11,GO:BP,protein localization to extracellular region,21010,17674,GO:0008104,FALSE
GO:0038026,0.00876165888356955,TRUE,7,112,3,GO:BP,reelin-mediated signaling pathway,21010,10146,GO:0007166,FALSE
GO:0034756,0.00876165888356955,TRUE,7,112,3,GO:BP,regulation of iron ion transport,21010,9133,GO:0006826|GO:0010959,FALSE
GO:0050670,0.00878117997525646,TRUE,237,112,9,GO:BP,regulation of lymphocyte proliferation,21010,13860,GO:0032944|GO:0046651|GO:0051249,FALSE
GO:0051099,0.00878363543946722,TRUE,178,112,8,GO:BP,positive regulation of binding,21010,14166,GO:0044093|GO:0051098,FALSE
GO:0002263,0.00921356746521745,TRUE,304,112,10,GO:BP,cell activation involved in immune response,21010,809,GO:0001775|GO:0002252|GO:0006955,FALSE
GO:0051129,0.0094014424129202,TRUE,709,112,15,GO:BP,negative regulation of cellular component organization,21010,14187,GO:0016043|GO:0048523|GO:0051128,FALSE
GO:0055082,0.0094014424129202,TRUE,709,112,15,GO:BP,intracellular chemical homeostasis,21010,14965,GO:0019725|GO:0048878,TRUE
GO:0098590,0.00948688896855818,TRUE,1304,112,19,GO:CC,plasma membrane region,22090,3224,GO:0005886|GO:0016020,FALSE
GO:0009617,0.00956205378001257,TRUE,710,112,15,GO:BP,response to bacterium,21010,3600,GO:0051707,FALSE
GO:0032944,0.0100558398487531,TRUE,241,112,9,GO:BP,regulation of mononuclear cell proliferation,21010,8301,GO:0032943|GO:0070663,FALSE
GO:0005496,0.0100810206450045,TRUE,101,108,6,GO:MF,steroid binding,20139,1484,GO:0008289|GO:0097159,FALSE
GO:0032370,0.0107371785090097,TRUE,85,112,6,GO:BP,positive regulation of lipid transport,21010,7888,GO:0006869|GO:0032368|GO:0051050|GO:1905954,FALSE
GO:0032934,0.0110057893289265,TRUE,61,108,5,GO:MF,sterol binding,20139,4511,GO:0005496,FALSE
REAC:R-HSA-8963896,0.0110141469144078,TRUE,7,100,3,REAC,HDL assembly,10835,1042,REAC:R-HSA-8963898,FALSE
GO:0051641,0.0114803245060262,TRUE,3652,112,39,GO:BP,cellular localization,21010,14550,GO:0009987|GO:0051179,FALSE
GO:0051128,0.0115049423493402,TRUE,2419,112,30,GO:BP,regulation of cellular component organization,21010,14186,GO:0016043|GO:0050794,FALSE
GO:0010817,0.0117322226542349,TRUE,545,112,13,GO:BP,regulation of hormone levels,21010,4508,GO:0065008,TRUE
GO:0006953,0.0118721110219358,TRUE,50,112,5,GO:BP,acute-phase response,21010,2626,GO:0002526,TRUE
GO:0051180,0.0118721110219358,TRUE,50,112,5,GO:BP,vitamin transport,21010,14236,GO:0006810,TRUE
GO:0030246,0.0120115661787683,TRUE,281,108,9,GO:MF,carbohydrate binding,20139,3883,GO:0005488,FALSE
GO:0046889,0.0122908863973659,TRUE,87,112,6,GO:BP,positive regulation of lipid biosynthetic process,21010,13057,GO:0008610|GO:0009891|GO:0045834|GO:0046890,FALSE
GO:0006094,0.0122908863973659,TRUE,87,112,6,GO:BP,gluconeogenesis,21010,1984,GO:0006006|GO:0019319,FALSE
GO:0010565,0.0124988095849875,TRUE,133,112,7,GO:BP,regulation of cellular ketone metabolic process,21010,4289,GO:0031323|GO:0042180|GO:0062012,FALSE
REAC:R-HSA-202430,0.0125191725588438,TRUE,20,100,4,REAC,Translocation of ZAP-70 to Immunological synapse,10835,2460,REAC:R-HSA-202403,FALSE
GO:0006796,0.0126677834467366,TRUE,2694,112,32,GO:BP,phosphate-containing compound metabolic process,21010,2521,GO:0006793,TRUE
GO:0061615,0.0129112307829777,TRUE,24,112,4,GO:BP,glycolytic process through fructose-6-phosphate,21010,16369,GO:0006096,FALSE
GO:0045591,0.0129112307829777,TRUE,24,112,4,GO:BP,positive regulation of regulatory T cell differentiation,21010,12057,GO:0045066|GO:0045582|GO:0045589,TRUE
GO:0046365,0.013106893368837,TRUE,51,112,5,GO:BP,monosaccharide catabolic process,21010,12714,GO:0005996|GO:0016052|GO:0044282,FALSE
GO:0048523,0.013735579411159,TRUE,5511,112,51,GO:BP,negative regulation of cellular process,21010,13456,GO:0009987|GO:0048519|GO:0050794,FALSE
GO:0002702,0.0137879899310066,TRUE,135,112,7,GO:BP,positive regulation of production of molecular mediator of immune response,21010,1234,GO:0002440|GO:0002699|GO:0002700|GO:0010628,FALSE
HP:0011031,0.0138828123183028,TRUE,28,54,5,HP,Abnormality of iron homeostasis,4962,7449,HP:0011030,FALSE
GO:1990459,0.013944919056389,TRUE,11,108,3,GO:MF,transferrin receptor binding,20139,11135,GO:0005102,FALSE
GO:0010898,0.013964148404617,TRUE,8,112,3,GO:BP,positive regulation of triglyceride catabolic process,21010,4567,GO:0010896|GO:0019433|GO:0031331|GO:0050996|GO:0090208,FALSE
GO:0002729,0.013964148404617,TRUE,8,112,3,GO:BP,positive regulation of natural killer cell cytokine production,21010,1261,GO:0002370|GO:0002717|GO:0002720|GO:0002727,FALSE
GO:0032092,0.0140221528474173,TRUE,89,112,6,GO:BP,positive regulation of protein binding,21010,7716,GO:0043393|GO:0051099,FALSE
GO:0006968,0.0144399232624355,TRUE,52,112,5,GO:BP,cellular defense response,21010,2638,GO:0006952,FALSE
GO:0019319,0.0149590308943896,TRUE,90,112,6,GO:BP,hexose biosynthetic process,21010,5939,GO:0019318|GO:0046364,FALSE
GO:0006793,0.0153698045769141,TRUE,2719,112,32,GO:BP,phosphorus metabolic process,21010,2518,GO:0044237,FALSE
GO:0005488,0.0163769966833605,TRUE,18282,108,108,GO:MF,binding,20139,1483,GO:0003674,FALSE
GO:0062080,0.0165662742932616,TRUE,2,108,2,GO:MF,inhibitory MHC class Ib receptor activity,20139,8607,GO:0032394,FALSE
GO:0062082,0.0165662742932616,TRUE,2,108,2,GO:MF,HLA-E specific inhibitory MHC class Ib receptor activity,20139,8609,GO:0062080,FALSE
GO:0038025,0.0165662742932616,TRUE,2,108,2,GO:MF,reelin receptor activity,20139,5538,GO:0004888,TRUE
CORUM:7359,0.0166859527145844,TRUE,2,21,2,CORUM,TF-TFRC complex,3383,2792,CORUM:0000000,FALSE
GO:0048260,0.0174227597224052,TRUE,54,112,5,GO:BP,positive regulation of receptor-mediated endocytosis,21010,13261,GO:0006898|GO:0045807|GO:0048259,FALSE
GO:0120009,0.0174227597224052,TRUE,54,112,5,GO:BP,intermembrane lipid transfer,21010,20375,GO:0006869|GO:0061024,FALSE
GO:0030154,0.0177494085015934,TRUE,4310,112,43,GO:BP,cell differentiation,21010,7002,GO:0048869,FALSE
GO:0048869,0.0178574519425224,TRUE,4311,112,43,GO:BP,cellular developmental process,21010,13764,GO:0009987|GO:0032502,FALSE
GO:0031667,0.0184539371968008,TRUE,484,112,12,GO:BP,response to nutrient levels,21010,7622,GO:0009991,FALSE
GO:0031323,0.0186757181137355,TRUE,6726,112,58,GO:BP,regulation of cellular metabolic process,21010,7461,GO:0019222|GO:0044237|GO:0050794,FALSE
GO:0007189,0.0192021343319364,TRUE,142,112,7,GO:BP,adenylate cyclase-activating G protein-coupled receptor signaling pathway,21010,2794,GO:0007188,TRUE
HP:0010981,0.0198003487195532,TRUE,30,54,5,HP,Hypolipoproteinemia,4962,7403,HP:0010979,FALSE
REAC:R-HSA-909733,0.0198643908312752,TRUE,71,100,6,REAC,Interferon alpha/beta signaling,10835,1176,REAC:R-HSA-913531,FALSE
GO:0046903,0.0204715608902001,TRUE,954,112,17,GO:BP,secretion,21010,13069,GO:0006810,FALSE
GO:0043382,0.0208647999973696,TRUE,9,112,3,GO:BP,positive regulation of memory T cell differentiation,21010,11170,GO:0002699|GO:0043379|GO:0043380|GO:0045582|GO:0050778,FALSE
GO:0002370,0.0208647999973696,TRUE,9,112,3,GO:BP,natural killer cell cytokine production,21010,916,GO:0002228|GO:0002367,FALSE
GO:0002727,0.0208647999973696,TRUE,9,112,3,GO:BP,regulation of natural killer cell cytokine production,21010,1259,GO:0002370|GO:0002715|GO:0002718,FALSE
GO:0030300,0.0208647999973696,TRUE,9,112,3,GO:BP,regulation of intestinal cholesterol absorption,21010,7074,GO:0030299|GO:0032374|GO:1904729,FALSE
GO:0015889,0.0208647999973696,TRUE,9,112,3,GO:BP,cobalamin transport,21010,5080,GO:0051180|GO:0071702|GO:0071705,FALSE
GO:0001915,0.0208647999973696,TRUE,9,112,3,GO:BP,negative regulation of T cell mediated cytotoxicity,21010,543,GO:0001911|GO:0001913|GO:0001914|GO:0002710,FALSE
GO:0001819,0.0208680540990385,TRUE,490,112,12,GO:BP,positive regulation of cytokine production,21010,486,GO:0001816|GO:0001817|GO:0010628|GO:0051240,FALSE
GO:0044092,0.0210340908976313,TRUE,956,112,17,GO:BP,negative regulation of molecular function,21010,11465,GO:0065009,FALSE
GO:0050671,0.0210376507164384,TRUE,144,112,7,GO:BP,positive regulation of lymphocyte proliferation,21010,13861,GO:0032946|GO:0046651|GO:0050670|GO:0051251,FALSE
GO:0050996,0.021062997456834,TRUE,27,112,4,GO:BP,positive regulation of lipid catabolic process,21010,14100,GO:0009896|GO:0016042|GO:0045834|GO:0050994,FALSE
GO:0032502,0.0212439803863087,TRUE,6414,112,56,GO:BP,developmental process,21010,7976,GO:0008150,FALSE
GO:0071248,0.021378883439467,TRUE,201,112,8,GO:BP,cellular response to metal ion,21010,17318,GO:0010038|GO:0071241,FALSE
HPA:0401331,0.0215261462270721,TRUE,544,67,12,HPA,rectum; mucosal lymphoid cells[Low],11006,568,HPA:0400000,FALSE
GO:0070663,0.0215501088477639,TRUE,265,112,9,GO:BP,regulation of leukocyte proliferation,21010,17047,GO:0042127|GO:0070661,FALSE
GO:0007165,0.0223160223103144,TRUE,5926,112,53,GO:BP,signal transduction,21010,2776,GO:0007154|GO:0009987|GO:0023052|GO:0050794|GO:0051716,FALSE
REAC:R-HSA-202427,0.0223993131317889,TRUE,23,100,4,REAC,Phosphorylation of CD3 and TCR zeta chains,10835,1668,REAC:R-HSA-202403,FALSE
GO:0002823,0.0227761247216877,TRUE,57,112,5,GO:BP,negative regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains,21010,1347,GO:0002460|GO:0002820|GO:0002822,FALSE
GO:0010033,0.0234587148475151,TRUE,2775,112,32,GO:BP,response to organic substance,21010,3903,GO:0042221,FALSE
GO:0032946,0.0240617418593932,TRUE,147,112,7,GO:BP,positive regulation of mononuclear cell proliferation,21010,8303,GO:0032943|GO:0032944|GO:0070665,FALSE
GO:0019222,0.0242594586994345,TRUE,7295,112,61,GO:BP,regulation of metabolic process,21010,5855,GO:0008152|GO:0050789,FALSE
GO:0030101,0.0244322387608248,TRUE,98,112,6,GO:BP,natural killer cell activation,21010,6994,GO:0046649,FALSE
GO:1903143,0.025059512717458,TRUE,3,112,2,GO:CC,adrenomedullin receptor complex,22090,3676,GO:0038037|GO:1903439,FALSE
GO:0042825,0.025059512717458,TRUE,3,112,2,GO:CC,TAP complex,22090,1847,GO:0042824|GO:0098796|GO:0140534,FALSE
WP:WP1533,0.0252775048015993,TRUE,51,87,5,WP,Vitamin B12 metabolism,8625,31,WP:000000,FALSE
WP:WP5049,0.0257157364407942,TRUE,11,87,3,WP,Glycolysis in senescence,8625,497,WP:000000,FALSE
GO:0005319,0.0257218645548406,TRUE,175,108,7,GO:MF,lipid transporter activity,20139,1417,GO:0005215,FALSE
GO:0046364,0.0258965563508086,TRUE,99,112,6,GO:BP,monosaccharide biosynthetic process,21010,12713,GO:0005996|GO:0016051|GO:0044283,FALSE
HPA:0471442,0.0258972403538632,TRUE,833,67,15,HPA,skin 2; fibrohistiocytic cells[Medium],11006,705,HPA:0471441,FALSE
GO:0019637,0.0264041514961724,TRUE,973,112,17,GO:BP,organophosphate metabolic process,21010,6235,GO:0006793|GO:0071704,FALSE
REAC:R-HSA-389948,0.0266893998196508,TRUE,24,100,4,REAC,PD-1 signaling,10835,1580,REAC:R-HSA-388841,FALSE
GO:0016042,0.0270384170673676,TRUE,344,112,10,GO:BP,lipid catabolic process,21010,5162,GO:0006629|GO:1901575,FALSE
GO:0030388,0.0296910172365629,TRUE,10,112,3,GO:BP,"fructose 1,6-bisphosphate metabolic process",21010,7100,GO:0006796|GO:0019637|GO:1901135,FALSE
GO:1904729,0.0296910172365629,TRUE,10,112,3,GO:BP,regulation of intestinal lipid absorption,21010,25053,GO:0032368|GO:0098856|GO:1904478,FALSE
GO:0070508,0.0296910172365629,TRUE,10,112,3,GO:BP,cholesterol import,21010,16961,GO:0030301,FALSE
GO:0070661,0.0298650406832203,TRUE,348,112,10,GO:BP,leukocyte proliferation,21010,17045,GO:0008283,FALSE
REAC:R-HSA-2424491,0.0315488185450696,TRUE,25,100,4,REAC,DAP12 signaling,10835,416,REAC:R-HSA-2172127,FALSE
TF:M04788,0.0323269318586597,TRUE,554,111,13,TF,Factor: IRF-1; motif: STTTCACTTTCNNT,20011,4260,TF:M00000,FALSE
GO:0009991,0.0328784634406406,TRUE,513,112,12,GO:BP,response to extracellular stimulus,21010,3873,GO:0009605,FALSE
GO:0036477,0.033124105476682,TRUE,849,112,14,GO:CC,somatodendritic compartment,22090,1723,GO:0110165,FALSE
GO:0050790,0.033962073138038,TRUE,1788,112,24,GO:BP,regulation of catalytic activity,21010,13917,GO:0065009,FALSE
WP:WP2007,0.0340379176207306,TRUE,12,87,3,WP,Iron metabolism in placenta,8625,578,WP:000000,FALSE
WP:WP4629,0.0340379176207306,TRUE,12,87,3,WP,Aerobic glycolysis,8625,177,WP:000000,FALSE
GO:0002820,0.0344621250415605,TRUE,62,112,5,GO:BP,negative regulation of adaptive immune response,21010,1344,GO:0002250|GO:0002819|GO:0050777,FALSE
REAC:R-HSA-5619049,0.0357359592899764,TRUE,2,100,2,REAC,Defective SLC40A1 causes hemochromatosis 4 (HFE4) (macrophages),10835,639,REAC:R-HSA-5619102,FALSE
REAC:R-HSA-5619060,0.0357359592899764,TRUE,2,100,2,REAC,Defective CP causes aceruloplasminemia (ACERULOP),10835,493,REAC:R-HSA-5619102,FALSE
REAC:R-HSA-5682113,0.0357359592899764,TRUE,2,100,2,REAC,Defective ABCA1 causes TGD,10835,441,REAC:R-HSA-5619084,FALSE
KEGG:05164,0.0362566464704195,TRUE,168,88,8,KEGG,Influenza A,8161,438,KEGG:00000,FALSE
GO:1901575,0.0368285929892299,TRUE,2173,112,27,GO:BP,organic substance catabolic process,21010,22444,GO:0009056|GO:0071704,FALSE
GO:0002507,0.0371479213031467,TRUE,31,112,4,GO:BP,tolerance induction,21010,1043,GO:0002376|GO:0002520,FALSE
HP:0200036,0.0376763325658395,TRUE,115,54,8,HP,Skin nodule,4962,16459,HP:0011355,FALSE
GO:0062014,0.0382527083484659,TRUE,106,112,6,GO:BP,negative regulation of small molecule metabolic process,21010,16575,GO:0009892|GO:0044281|GO:0062012,FALSE
GO:0007162,0.038345320225311,TRUE,285,112,9,GO:BP,negative regulation of cell adhesion,21010,2773,GO:0007155|GO:0030155|GO:0048523,FALSE
GO:0042180,0.0384103366448242,TRUE,218,112,8,GO:BP,cellular ketone metabolic process,21010,10507,GO:0044237|GO:0044281|GO:0071704,FALSE
GO:0043086,0.0399917114549938,TRUE,612,112,13,GO:BP,negative regulation of catalytic activity,21010,11025,GO:0044092|GO:0050790,FALSE
HP:0003107,0.0401307658581726,TRUE,116,54,8,HP,Abnormal circulating cholesterol concentration,4962,2238,HP:0003119,FALSE
GO:0010985,0.0406665234475145,TRUE,11,112,3,GO:BP,negative regulation of lipoprotein particle clearance,21010,4644,GO:0010984|GO:0034381|GO:0051241,FALSE
GO:2001198,0.0406665234475145,TRUE,11,112,3,GO:BP,regulation of dendritic cell differentiation,21010,27495,GO:0097028|GO:1902105,TRUE
GO:0002719,0.0422807819006611,TRUE,32,112,4,GO:BP,negative regulation of cytokine production involved in immune response,21010,1251,GO:0001818|GO:0002367|GO:0002701|GO:0002718,FALSE
HPA:0030442,0.0424114461767983,TRUE,263,67,8,HPA,appendix; non-germinal center cells[Medium],11006,48,HPA:0030441,FALSE
HP:0011034,0.0432817139287411,TRUE,35,54,5,HP,Amyloidosis,4962,7452,HP:0001939,FALSE
HPA:0481291,0.043997674645308,TRUE,499,67,11,HPA,small intestine; endocrine cells[Low],11006,726,HPA:0480000,FALSE
HPA:0151291,0.043997674645308,TRUE,499,67,11,HPA,duodenum; endocrine cells[Low],11006,257,HPA:0150000,FALSE
GO:0050793,0.0469690462527035,TRUE,2465,112,29,GO:BP,regulation of developmental process,21010,13919,GO:0032502|GO:0050789,FALSE
KEGG:05152,0.0476042054369541,TRUE,175,88,8,KEGG,Tuberculosis,8161,433,KEGG:00000,FALSE
GO:0007267,0.0476298867566712,TRUE,1703,112,23,GO:BP,cell-cell signaling,21010,2846,GO:0007154|GO:0023052,FALSE
GO:0019725,0.0478415932025477,TRUE,814,112,15,GO:BP,cellular homeostasis,21010,6303,GO:0042592,FALSE
GO:1904435,0.0485603238525496,TRUE,2,112,2,GO:BP,regulation of transferrin receptor binding,21010,24808,GO:1900120,FALSE
GO:1904434,0.0485603238525496,TRUE,2,112,2,GO:BP,positive regulation of ferrous iron binding,21010,24807,GO:0051099|GO:1904432,FALSE
GO:1904432,0.0485603238525496,TRUE,2,112,2,GO:BP,regulation of ferrous iron binding,21010,24805,GO:0051098,FALSE
GO:0034445,0.0485603238525496,TRUE,2,112,2,GO:BP,negative regulation of plasma lipoprotein oxidation,21010,9038,GO:0034441|GO:0034444|GO:0051129|GO:0051241,FALSE
GO:1904437,0.0485603238525496,TRUE,2,112,2,GO:BP,positive regulation of transferrin receptor binding,21010,24810,GO:1900122|GO:1904435,TRUE
GO:0034444,0.0485603238525496,TRUE,2,112,2,GO:BP,regulation of plasma lipoprotein oxidation,21010,9037,GO:0034441|GO:0051128|GO:0051239,FALSE
GO:0002469,0.0485603238525496,TRUE,2,112,2,GO:BP,myeloid dendritic cell antigen processing and presentation,21010,1006,GO:0002468,TRUE
GO:0002481,0.0485603238525496,TRUE,2,112,2,GO:BP,"antigen processing and presentation of exogenous protein antigen via MHC class Ib, TAP-dependent",21010,1018,GO:0002477,FALSE
GO:0002485,0.0485603238525496,TRUE,2,112,2,GO:BP,"antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway, TAP-dependent",21010,1022,GO:0002484,FALSE
GO:0002590,0.0485603238525496,TRUE,2,112,2,GO:BP,negative regulation of antigen processing and presentation of peptide antigen via MHC class I,21010,1125,GO:0002474|GO:0002584|GO:0002589,FALSE
GO:0002589,0.0485603238525496,TRUE,2,112,2,GO:BP,regulation of antigen processing and presentation of peptide antigen via MHC class I,21010,1124,GO:0002474|GO:0002583,FALSE
GO:0010902,0.0485603238525496,TRUE,2,112,2,GO:BP,positive regulation of very-low-density lipoprotein particle remodeling,21010,4571,GO:0010901|GO:0034372|GO:0051130|GO:0051240,FALSE
GO:0002491,0.0485603238525496,TRUE,2,112,2,GO:BP,antigen processing and presentation of endogenous peptide antigen via MHC class II,21010,1028,GO:0002483|GO:0002495,FALSE
GO:0060621,0.0485603238525496,TRUE,2,112,2,GO:BP,negative regulation of cholesterol import,21010,15537,GO:0032375|GO:0060620|GO:0070508,FALSE
GO:0070665,0.0487998370998636,TRUE,164,112,7,GO:BP,positive regulation of leukocyte proliferation,21010,17049,GO:0008284|GO:0070661|GO:0070663,FALSE
GO:0023025,0.049524415065802,TRUE,3,108,2,GO:MF,MHC class Ib protein complex binding,20139,3843,GO:0023023,FALSE
GO:0001605,0.049524415065802,TRUE,3,108,2,GO:MF,adrenomedullin receptor activity,20139,210,GO:0097642,FALSE
GO:0030226,0.049524415065802,TRUE,3,108,2,GO:MF,apolipoprotein receptor activity,20139,3877,GO:0038024,FALSE
GO:0042610,0.049524415065802,TRUE,3,108,2,GO:MF,CD8 receptor binding,20139,5660,GO:0005102,FALSE
REAC:R-HSA-9705671,0.0496657823146089,TRUE,120,100,7,REAC,SARS-CoV-2 activates/modulates innate and adaptive immune responses,10835,2017,REAC:R-HSA-9705683,FALSE
GO:0002526,0.0496899403790527,TRUE,111,112,6,GO:BP,acute inflammatory response,21010,1062,GO:0006954,FALSE
CORUM:143,0.0498703200771593,TRUE,3,21,2,CORUM,APP-APBB1-LRP1 complex,3383,72,CORUM:0000000,FALSE
CORUM:2710,0.0498703200771593,TRUE,3,21,2,CORUM,LRP-1-Alpha-2-M-annexin VI complex,3383,1142,CORUM:0000000,FALSE
GO:0000015,0.049952691253446,TRUE,4,112,2,GO:CC,phosphopyruvate hydratase complex,22090,1,GO:0005829|GO:1902494,TRUE
GO:0070724,0.049952691253446,TRUE,4,112,2,GO:CC,BMP receptor complex,22090,2552,GO:0098802,FALSE
